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ABSTRACT OF THE DISSERTATION
Predictors of Neuropsychological Status in Cardiac Patients
by
Joel E. Kamper
Doctor of Philosophy, Graduate Program in Clinical Psychology
Loma Linda University, September 2013
Dr. Susan A. Ropacki, Chairperson

Heart Disease is one of the leading causes of death and disability in the United
States. Disease processes such as Coronary Artery Disease (CAD) and Chronic Heart
Failure (CHF) account for the majority of cases, and are responsible for Myocardial
Infarctions (MI), Coronary Artery Bypass Grafting (CABG) surgery, and other common
disease sequelae and treatment paradigms. While the fact that heart can negatively
impact cognitive functioning is well documented, the factors that drive changes in
cognition have not been studied in depth. Additionally, while many heart patients choose
to enter cardiac rehabilitation (CR) programs designed to decrease morbidly and
mortality, most do not. This study used hierarchical regression models to test these two
aims. heart patients entering rehabilitation or electing not to participate were assessed
using a chart review, standardized neuropsychological measures, and standard
questionnaires, with a final sample size of 52 (11 controls, 41 rehabilitation subjects).
For Aim 1, health (hypertension, CHF, surgery history), and cognitive reserve (education,
premorbid IQ) variables successfully predicted the cognitive status of heart patients
across several functional domains, while affective factors (depression, anxiety, stress)
were less predictive. For Aim 2, cognitive variables were not significantly associated
with whether or not a patient adheres to cardiac rehabilitation. Results indicate that

xi

multiple health and cognitive reserve-related factors impact cognitive functioning.
Helping heart patients manage or compensate for identified risk factors could help
mediate morbidity and mortality.

xii

CHAPTER ONE
INTRODUCTION

Heart Disease is a major health problem, accounting for 25% of all deaths in the
United States (Xu, Kochanek, Murphy, & Tejada-Vera, 2010). This umbrella term
contains diagnoses including Coronary Artery Disease (CAD); which includes
myocardial infarction (MI), cardiomyopathy, and ischemic heart disease; as well as
congestive heart failure (CHF/HF); and hypertensive heart disease. Together, these
diseases are responsible for $475.3 billion in direct and indirect costs (Cardiovascular
Disease Costs and Statistics), making cardiovascular diseases the highest cause of
mortality in the United States. Besides the direct health-related factors of heart disease,
individuals that live long term with these conditions often experience fatigue, depressive
symptoms, and dyspnea which can further contribute to diminished treatment adherence
and reduced quality of life (Bennett & Sauve, 2003).
The ability of heart patients to have a positive quality of life, make positive
health-related decisions, and perform adequate self-care can be further compromised by
cognitive deficits, which have been noted to occur in up to 80% of individuals with
diseases such as CHF (Pressler, 2008). A high overlap in the risk factors, signs, and
medical procedures associated with heart disease and cognitive dysfunction has been
noted (Moser et al., 1999), with MI, CAD-related surgical procedures, and CHF most
strongly associated with cerebral insult and neuropsychological dysfunctions (Hammeke
& Hastings, 1988; Moser, et al., 1999; Roine, Kajaste, & Kaste, 1993; Savageau, Stanton,
Jenkins, & Frater, 1982; Savageau, Stanton, Jenkins, & Klein, 1982; van Swieten et al.,
1991). Thus, the disease and treatment processes related to heart disease can directly
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impact a patient’s affective functioning and cognitive functioning, leading to a
diminished ability to participate in self-care (Moser, et al., 1999). Cognitive impairments
can also contribute to diminished quality of life and increased mortality (Pressler et al.,
2010a, 2010b).
The field of heart disease-associated cognitive dysfunction is relatively new.
However, general domains of impairment have been documented, and include attention,
learning and memory, psychomotor speed, and executive functioning (Bauer & Pozehl,
2010; Pressler, Subramanian, et al., 2010a, 2010b). While deficits in these areas have
been documented, it is unclear exactly how they relate to health markers, premorbid
intellectual abilities, and affective factors. This study seeks to fill this gap in the
literature by examining the predictive relationship between health markers, intellectual
ability, and affective functioning on the overall cognitive abilities and impairments in
heart patients by examining the impact of these predictors on cognitive status for a
heterogeneous sample of heart patients.
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CHAPTER TWO
REVIEW OF THE LITERATURE

Coronary Artery Disease
Coronary Artery Disease is a disease process in which plaque accumulates within
the arteries supplying blood to the heart (Coronary Artery Disease, 2009). As of 2007,
CAD accounted for half of all heart-related deaths, making it the largest cause of
mortality for a single disease (Cardiovascular Disease Costs and Statistics; Xu, et al.,
2010). While most individuals have some arterial plaque buildup, CAD is generally not
diagnosed unless a patient manifests clinical symptoms. This lack of parity between
disease onset and diagnosis dictates that patients will often need immediate intervention
to account for the undetected progression of disease processes (Xu, et al., 2010).

Mechanisms of CAD
At its most basic level, CAD involves atherosclerosis, in which fat, cholesterol,
and other substances build up in the arteries perfusing the myocardium (Coronary Artery
Disease, 2009; Jezierska-Wozniak, Mystkowska, Tutas, & Jurkowski, 2011). This in
turn leads to a restriction of functioning, which can lead to angina – chest pain, or a
myocardial infarction. If left untreated, CAD will often lead to CHF (Coronary Artery
Disease, 2009).
The progression from plaque formation to clinical symptoms can take many years,
as plaques are generally slow-forming (Libby, 1995). However, well-known risk factors
such as hypercholesterolemia, hypertension, diabetes, obesity, and left ventricular
hypertrophy can exacerbate plaque formation, acting synergistically and enhancing CAD
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risk (Dzau, 1990). In a healthy person, hemodynamic factors such as serum lipids,
platelets, and vessel walls maintain a necessary balance. However, chronic conditions
such as hypertension and obesity can affect blood flow physics, causing changes in the
vascular wall itself that in turn promote aggregation of cholesterol and other substances
into plaques (Dzau, 1990; Ross, 1986).
Furthermore, the high cholesterol and oxidative stress present in common chronic
diseases such as hypercholesterolemia, hypertension, and diabetes can impact the
function of the endothelial cells lining blood vessels (Aronson & Edelman, 2010; Kalay
et al., 2010; Kinlay, Libby, & Ganz, 2001). The endothelium is responsible for
regulating the vessel and responding to physiological and hemodynamic changes (Kalay,
et al., 2010). However, lipids and oxidative stress can reduce the bioavailability of nitric
oxide and activate pro-inflammatory signaling pathways (Kalay, et al., 2010). These
physiological changes, together with biomechanical changes in the vessel affect
endothelial cell functioning, hastening the deposition of plaques and increasing the
chance for an acute coronary event (Kinlay, et al., 2001).
While atherosclerosis is defined by the presence of plaque depositions, not all
plaques are alike (Libby, 1995). Typical plaques contain a lipid-rich core that is imbibed
with macrophage foam cells derived from blood monocytes. The combination of lipids
and macrophages causes a large production of tissue factor, a powerful procoagulant that
stimulates thrombus or clot formation if it comes in contact with blood (Libby, 1995).
Typical plaques also contain a fibrous cap or extracellular matrix that overlays the lipidrich core. This cap must resist the high stresses in the arterial lumen to prevent the
development of an acute coronary event. Thus, it is the integrity of this cap that
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determines how stable a plaque will be. Plaques prone to rupturing (thus producing a
thrombus) tend to have thin caps, while plaques with thicker caps tend to be much more
stable (Libby, 1995). Collagens are mostly responsible for the strength and durability of
the fibrous cap. Chronic inflammation and immune stimulation, as well as the inhibition
of smooth muscle along the vessel can cause a cascade of physiological changes that
inhibits collagen synthesis, leading to a weaker cap (Libby, 1995).

Health Effects
CAD is a condition that includes a series of clinical manifestations. Coronary
atherosclerosis itself, which is at the crux of the disease, can be classified into five phases
(Doering, 1999). These phases include slow progression, intermediate progression with
plaque development, rapid progression with plaque development, development of
occlusions, and development of stenotic plaques. The plaques and lesions involved in
these phases range from the symptomless, slow-progressing lipid buildups present in
people as young as 30 (phase 1) to more rapidly-progressing plaques (phases 3+) that
become more complex in their makeup and geometry (Doering, 1999). The more
complex and rapid the plaque buildup, the greater chance the plaque may rupture, leading
to an acute event such as a myocardial infarction (MI) (Doering, 1999; Gutstein & Fuster,
1999). Each phase thus corresponds to specific symptoms, ranging from mild angina or
chest pain to MI or sudden cardiac death (SCD), as well as to more chronic-like disease
processes (Doering, 1999; El-Sherif, Khan, Savarese, & Turitto, 2010; Gutstein & Fuster,
1999). While most individuals meet criteria for at least phase 1, the absence of clinical
symptoms below phase 3 suggests that by the time an individual is showing early CAD
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symptomotology such as angina they already possesses complicated plaques with at least
partial occlusion of cardiac arteries (Doering, 1999).
Perhaps the most well-known manifestation of CAD is myocardial infarction
(MI). It is defined as the sudden interruption of blood flow in the arteries perfusing the
heart, leading to ischemia and subsequent death of heart tissue (the myocardium). This
event is often caused by the sudden rupture of unstable atherosclerotic plaques with thin
caps, which tend to clot when their lipid-rich core come in contact with blood. This in
turn causes a thrombus which cause the actual blockage (Maseri, 2000). While an MI
can seem like a sudden event, it is actually affected by at least three major components
(Maseri, 1990). These include a patient’s chronic atherosclerotic background, the actual
ischemia due to thrombosis (arterial clotting), and the heart’s reaction in terms of
arrhythmias. Thus, individual differences exist in a CAD patient’s risk for MI as well as
an individual’s myocardial response to the infarct (Maseri, 1990). Furthermore, the type
and stability of an individual’s plaques is integral to the risk of thrombosis, as weaker,
less stable plaques are more likely to rupture. Finally, any sudden change in heart
function or activity due to excessive exercise or psychosocial stress may exacerbate the
immediate risk of an MI (Maseri, 2000).

Treatment
Treatment for CAD can involve several procedures with varying levels of
invasiveness. These treatments fall into one of two categories: Pharmacological and
surgical methods (Lamy, Natarajan, & Yusuf, 2011). Typically, patients will first
undergo an angiogram, which images the heart and surrounding blood vessels (Michaels
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& Chatterjee, 2002). This procedure helps the medical team determine the severity of the
disease, which will largely dictate the type of procedure performed (Michaels &
Chatterjee, 2002). If a patient has arterial narrowing that does not limit coronary blood
flow, the disease is most often treated with medications and lifestyle modifications (diet,
exercise, etc.). If the atherosclerosis does limit blood flow, surgical procedures are often
used (Michaels & Chatterjee, 2002).
Pharmacological and lifestyle treatments are utilized to reduce symptoms of
angina and to improve health outcomes in patients with less severe CAD (Michaels &
Chatterjee, 2002). Typically, anti-anginal medications such as beta-blockers and calcium
channel blockers work to minimize angina through either reducing the heart’s oxygen
requirements or increasing the amount of arterial blood flow. Medications such as
aspirin, cholesterol-lowering drugs and beta-blockers can reduce the risk of death
associated with CAD through reducing clotting factors associated with thrombus
formation and blocking the harmful effects of hormones that contribute to atherosclerosis
(Michaels & Chatterjee, 2002).
Lifestyle changes are also used to help prevent the build-up of lipids and to
improve overall health and functioning (Carles et al., 2007; Michaels & Chatterjee,
2002). These changes include smoking cessation, a diet low in cholesterol and fat,
regular exercise, weight loss, diabetes management, and blood pressure control. These
lifestyle changes are equally as important as medications for patients who undergo
surgery, as they help maximize the efficacy of surgical interventions (Michaels &
Chatterjee, 2002).
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Surgically, several procedures are commonly used to treat CAD (Lamy, et al.,
2011). These include percutaneous coronary interventions (PCI), which includes
angioplasty and stents, as well as coronary artery bypass grafting (CABG) surgery
(Lamy, et al., 2011). If the atherosclerosis is largely contained to one vessel, balloon
angioplasty and stents are often utilized (Michaels & Chatterjee, 2002). These
procedures, administered in up to 33% of CAD patients, are generally less costly and less
invasive than CABG surgery and often as effective in the relief of angina and other
symptoms (Stroupe et al., 2006). Angioplasty involves a balloon-tipped catheter being
inserted into the problematic artery. The balloon is subsequently inflated to push plaque
back against the arterial wall. Additionally, the plaque may be cut away using the
catheter itself. After removal or compaction of the plaque, wire-mesh stents are inserted
into the artery to support the damaged arterial wall and reduce the chance for recurrence
of ischemia (Michaels & Chatterjee, 2002). These stents may be coated with
pharmacological agents to assist in keeping the artery functional. While angioplasty and
stenting is useful for many patients, a narrow or completely blocked artery is not
amenable to these procedures (Michaels & Chatterjee, 2002).
Patients with severe coronary plaques often undergo CABG surgery (Lamy, et al.,
2011; Michaels & Chatterjee, 2002; Silbert, Scott, Evered, Lewis, & Maruff, 2007;
Stroupe, et al., 2006). Up to 10% of CAD patients will have a CABG procedure
performed, which is usually indicated when multiple arteries are blocked or narrowed, or
when a main coronary artery becomes blocked. The procedure involves healthy veins or
arteries from the leg, chest, or arm being grafted around the blocked portion to restore
blood flow (Michaels & Chatterjee, 2002). The number of bypasses refers to the number
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of grafts that were utilized, based on how many coronary arteries were blocked.
Although angioplasty is less invasive and initially less costly, CABG procedures are
often superior in the long-term relief on angina in some patients due to the necessity to
periodically repeat a PCI procedure (Lamy, et al., 2011).

Congestive Heart Failure
Congestive heart failure is a disease process characterized by a failure of the
myocardium to adequately pump blood, and is defined as the condition in which
abnormal heart function causes blood delivery insufficient to satisfy the metabolic
requirements of organs and bodily systems (Rengo et al., 1996; "What is Congestive
Heart Failure?," 2004). As of 2010, there are 6 million persons with a HF diagnosis in
the United States, with both the prevalence and incidence continuing to grow (LloydJones et al., 2009; Pressler, 2008; Pressler, Subramanian, et al., 2010b).
While HF can affect anyone, it is primarily a disease of aging (Rengo, et al.,
1996). Beginning with a 3% incidence rate between ages 45-64, the prevalence roughly
doubles with every decade of increased age (Rengo, et al., 1996; Schocken, Arrieta,
Leaverton, & Ross, 1992). CHF is often caused by severe CAD, representing a
continuous disease process with CHF being generally more chronic and serious than
CAD (Bennett & Sauve, 2003; Vogels et al., 2007; Vogels, Scheltens, Schroeder-Tanka,
& Weinstein, 2007; "What is Congestive Heart Failure?," 2004). Indeed, CAD and CHF
are so closely linked that 75% of patients with CAD or related hypertension with develop
CHF (McKee, Castelli, McNamara, & Kannel, 1971; Rengo & Acanfora, 1994). CADrelated causes include severely clogged arteries and past heart damage due to MI.
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Other suggested etiologies for CHF include hypertension, myocardial infarction,
congenital defects, ischemic heart disease and valvulopathies (McKee, et al., 1971;
Rengo & Acanfora, 1994; "What is Congestive Heart Failure?," 2004), with the risk of
developing CHF associated with hypertension being much lower than that with a sudden
ischemic event (Rengo & Acanfora, 1994). The fact that different studies have found
varying etiologies suggests a multifactor risk model, which does not preclude the
possibility of other, extra-cardiac factors such as diet and smoking (Rengo & Acanfora,
1994; Rengo, et al., 1996; Rengo, Ferrara, & Leosco, 1991).

Mechanisms of CHF
At an essential level, CHF happens when the inability of the heart to maintain
adequate tissue perfusion causes a series of changes which includes the body’s attempt to
rectify the deficiency, leading to other problems that may further hamper circulation such
as hemodynamic changes and complex biochemical modulations (Rengo, et al., 1996).
The inability of the heart to maintain adequate perfusion is primarily caused by the loss
of myocardial tissue, reduction of contractility, pressure and volume overload, or
restrictive myocardial diseases, and is often mediated by CAD (Rengo, et al., 1996).
The loss of myocardial tissue may occur along several pathways. The most
dramatic loss of tissue is caused by ischemic events such as a myocardial infarction
which can quickly cause the loss of contractile tissue, lessening the heart’s ability to
maintain adequate tissue perfusion (Rengo, et al., 1996). When coupled with other CHFrelated sequelae such as reduced contractility, an ischemic event can have broad
consequences (Rengo & Acanfora, 1994). Adding to the loss of myocardial tissue is the
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general-age related decline in myocytes, or muscle fibers, noted in the ageing heart
(Olivetti, Melissari, Capasso, & Anversa, 1991). While not a causative factor in and of
itself, the general decline in myocytes can further hamper an already damaged heart’s
functional ability.
The reduction of myocardial contractility describes the condition where the heart
possesses a decreased ability to contract. This in turn hampers its ability to adequately
pump blood and maintain necessary perfusion. The functional loss of optimum
contraction is complex and depends on several factors (Rengo, et al., 1996). These
include a loss of myocardial tissue and muscular fibers due to a disease like CAD;
intrinsic myocardial depression seen with age; circulating catecholamines; autonomic
nervous system dysfunction; anoxia; hypercapnia, or excess carbon dioxide in the blood;
and acidosis, or excess blood acidity (Rengo, et al., 1996). Because of the multiple
factors that can affect contractility, most patients presenting with CHF will possess a
large number of the above causative factors. Thee fact that CHF is so closely related to
CAD, yet possesses a multi-factor causative model, may explain why some CAD patients
develop CHF while others do not.
Pressure and volume overload refer to dysfunction in the amount of blood being
pumped. Healthy elderly individuals possess a relatively unchanged ejection fraction,
defined as the volumetric fraction of blood pumped with each cycle, compared with their
younger counterparts (Rengo, et al., 1996; Rodeheffer et al., 1984), suggesting that blood
volume is not problematic for the ageing heart when it is not being stressed. However,
the aged myocardium does show a deceased ejection fraction during physical activity
when compared with younger hearts (Rodeheffer, et al., 1984). This is due to the fact
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that, in the elderly, physical stress induces smaller changes in heart rate than in younger
people. Patients who are at risk for CHF generally have lower resting ejection fractions
than their same-aged healthy counterparts, and may demonstrate an increase in left
ventricular volume as a compensatory measure as the heart tries to adequately perfuse the
body with blood (Rengo, et al., 1996; Rodeheffer, et al., 1984). This volumetric increase
and reduction in aortic compliance often leads to increased blood pressure. The pressure
overload in turn triggers myocardial cells to induce cellular hypertrophy, leading to a
further enlarged heart (Olivetti, et al., 1991).
Restrictive myocardial diseases can often occur as a result of cardiac hypertrophy
(Hansford & Castro, 1982; Rengo, et al., 1996). This is due to remodeling of the
myocardium in response to hypertrophy, leading to diastolic stiffness. Additionally, left
ventricular compliance can decrease, leading to further stiffness (Litwin & Grossman,
1993). The pathological restricting of myocardial tissue is compounded in elderly
patients, who often show an age-dependent alteration in left ventricle functioning
(Nicolino et al., 1993; Rengo, et al., 1996).

Health Effects
CHF causes a large number of non-cognitive health effects. As CHF is often the
result of a disease process such as CAD, the clinical manifestations of CHF itself are
often overshadowed by other symptoms, especially in elderly patients (Rengo, et al.,
1996). Non-specific symptoms such as peripheral edema often occur in CHF, but are not
indicative of nor exclusive to this disease process. Other non-specific but common
symptoms include severe shortness of breath and fatigue in CHF patients. Progressive
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difficulty with physical movement associated with CHF may eventually largely confine a
patient to bed (Dolgin, 1994). More specific effects of CHF include increased jugular
venous pressure, as well as decreased left ventricle ejection fraction and increased left
ventricle volume (Nicolino, et al., 1993; Rengo, et al., 1996), which are related to
common but non-specific effects like fatigue.
Although edema is not specific to CHF, it is one of the most often observed
clinical effects ("Congestive Heart Failure," 2011; Rengo, et al., 1996). This can be due
to several related factors. As blood flow out of the heart slows and the myocardium
weakens, venous blood in the extremities backs up due to the myocardium’s inability to
retrieve it through diastolic contraction. This is especially true in the legs and ankles,
where swelling due to edema is common due to their distance from and location below
the myocardium. Edema is also common in the lungs, which can interfere with
breathing, cause shortness of breath, and interfere with beneficial activities like exercise
("Congestive Heart Failure," 2011). As an additive factor, decreased blood flow to the
kidneys interferes with their ability to excrete sodium and maintain adequate
homeostasis. This in turn causes more edema. Given enough time, edema will affect
most organs in the body.
A common way to classify the extent of CHF and its health effects is using the
New York Heart Association (NYHA) Functional Classification Index (Dolgin, 1994).
Using this scale, patients are put in one of four categories based on how limited they are
in their physical activity, their ability to breathe normally, and their level of pain.
Patients in Class I (mild) have no undue fatigue or shortness of breath in ordinary
physical activity like walking or climbing stairs. Those in Class II (mild) have fatigue,
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palpitations, or shortness of breath during normal physical activity, but are comfortable at
rest. Those in Class III (moderate) are also comfortable at rest, but experience symptoms
during less-than ordinary physical activity such as walking short distances. Those in
Class IV (severe) have symptoms even at rest, and are unable to carry out any physical
activity without discomfort (Dolgin, 1994).

Treatment
CHF patients are often treated with a combination of drugs and lifestyle changes
(Kostis, Rosen, Cosgrove, Shindler, & Wilson, 1994; Morrissey, Czer, & Shah, 2011).
Past treatment modalities were relegated to diuretics and digoxin, with the purpose of
reducing edema and controlling the arrhythmias common in CHF patients. While these
drugs are useful in decreasing morbidity and reducing hospital admission rates, their use
as front-line treatments to improve mortality has waned in favor of newer pharmacologic
solutions (Haji & Movahed, 2000). Beta-blockers, once contraindicated for CHF due to
their effect on heart rhythm are now being used in combination with other drugs to
improve left ventricular function and thereby improve mortality (Morrissey, et al., 2011;
Rengo, et al., 1996). Other drugs, such as Angiotensin-Converting Enzyme (ACE)
inhibitors are also commonly use to increase cardiac output and volume, and to decrease
edema through more efficient sodium excretion (Morrissey, et al., 2011). However,
though the number of beneficial pharmacologic therapies for both mortality and
morbidity have increased, leading to improved survival, certain cardiomyopathies still
remain difficult to treat. Furthermore, hospital admission due to CHF morbidity remains
the single most common reason for hospital admission in our aging population
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(Morrissey, et al., 2011), suggesting that drugs alone are not sufficient to adequately
address CHF symptoms.
Over the past decade or so, non-pharmacologic treatment modalities have been
increasingly employed to supplement pharmacotherapy in CHF (Kostis, et al., 1994;
Smeulders et al., 2010). Interventions such as exercise training, dietary control of weight,
and psychological interventions are often utilized to enhance functional capacity,
improve quality of life, and improve survival rates in synergy with medication regimens
(Kostis, et al., 1994). Although CHF patients often experience difficulty exercising due
to pulmonary edema and other CHF-related factors, combination rehabilitation programs
including exercise training, cognitive therapy, and dietary education and management can
initiate significant improvements in exercise tolerance, weight loss, and symptoms of
depression and anxiety (Kostis, et al., 1994). The inefficacy of these treatments to
improve ejection fraction illustrates that combination drug and behavioral regimens lead
to the best outcomes. Structured self-management programs can also be effective,
especially for patients with better cognitive status and lower education (Smeulders, et al.,
2010).

Cardiac Rehabilitation
Cardiac Rehabilitation (CR) programs are coordinated, multifaceted interventions
designed to optimize a heart patient’s functioning while stabilizing, slowing, or reversing
the underlying physiological disease processes (Leon et al., 2005). While once of a
singular focus, they now involve a patient’s physical, psychological, and social
functioning which, when combined with disease process management, can best reduce
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morbidity and mortality (Lavie & Milani, 2011; Leon, et al., 2005). Because they are no
longer limited to exercise training, CR programs are now used as both treatment
programs for those with CHF or symptomatic CAD as well as prevention programs to
reduce modifiable heart disease risk factors (Gunstad et al., 2005; Leon, et al., 2005).
This broadening in scope also means that CR programs include patients with diverse
sequelae such as heart transplant candidates/recipients, CHF patients, CAD patients with
or at risk for MI, CAD patients who have undergone surgical procedures, those with
valvular disease, and patients with pulmonary disease (Leon, et al., 2005). CR programs
are typically offered to all cardiac patients as a recommended option for treatment.
Rehabilitation programs are multidisciplinary and designed to benefit patients’
overall health. Thus, programs are often individualized and involve exercise training,
dietary therapy, risk factor modification including medications, psychoeducation
sessions, psychological interventions including depression and anger management, and
cardioprotective therapies to reduce weight and increase metabolism (Lavie & Milani,
2011; Leon, et al., 2005; Luszczynska & Cieslak, 2009). CR has proven very beneficial,
with decreased morbidity, lower mortality and lowered risk of secondary disease process
development seen in patients who attend these programs (Lavie & Milani, 2011; Leon, et
al., 2005). Younger patients (<65) are especially able to benefit from these
multidisciplinary programs, with older patients (>65) deriving most of their benefit from
exercise alone (Ferrara et al., 2006) However, because CR attendance is often not well
enforced or advertised, only about 10-20% of eligible patients actually attend (Leon, et
al., 2005).
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Compared with healthy control subjects, heart patients entering CR tended to have
impaired attention, learning and memory, psychomotor speed, and executive functioning
(Moser, et al., 1999). While this is no different from the general heart disease population,
it does indicate that cognitive impairment may impact CR patients’ ability to benefit from
the program (Kakos et al., 2010; Moser, et al., 1999). However CR programs
themselves, through their multidisciplinary designs, can improve patients’ cognitive
abilities (Gunstad, et al., 2005). This is especially true in the domains of attention,
memory, and psychomotor speed, which both improved after CR (Carles, et al., 2007;
Gunstad, et al., 2005; Stanek et al., 2011). While patients may show executive gains,
improved executive functioning is not as likely and represents a moderator for the health
benefits an impaired patient can receive from CR programs (Kakos, et al., 2010; Stanek,
et al., 2011).

Cognitive Impairments
Cognitive impairment (CI) is common in heart patients (Bennett & Sauve, 2003;
Roine, et al., 1993; Savageau, Stanton, Jenkins, & Frater, 1982; Savageau, Stanton,
Jenkins, & Klein, 1982; Vogels, Scheltens, et al., 2007), with some cognitive dysfunction
occurring in up to 80% of hospitalized and chronic CHF patients, and up to 35% in less
severe CAD patients who undergo surgical procedures (Kneebone, Andrew, Baker, &
Knight, 1998; Pressler, Kim, Riley, Ronis, & Gradus-Pizlo, 2010). The presence of CI in
heart patients represents a major cause of morbidity, leading to worse overall outcomes as
well as an increased risk of mortality (Hogue et al., 2006; Zuccala et al., 2003). Among
those who have significant cognitive impairments, current performance on
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neuropsychological tests is equivalent with healthy individuals five years older (Elwood,
Pickering, Bayer, & Gallacher, 2002). Cognitive deficits have been indicated in all
groups of heart patients, including those who have CAD and CHF (Silbert, et al., 2007;
Vogels, Oosterman, et al., 2007). Impairment in CAD patients includes those who have
had an MI (Roine, et al., 1993) and those that have undergone cardiac surgery such as
CABG (Savageau, Stanton, Jenkins, & Frater, 1982; Savageau, Stanton, Jenkins, &
Klein, 1982). There is even evidence of pre-surgical cognitive impairment in CAD
patients (Hogue, et al., 2006), suggesting that both surgical intervention and the actual
heart disease processes contribute to cognitive dysfunction. The role of heart disease in
CI is so central that CHF is indicated as one of the major risk factors for dementia in
elderly patients (Acanfora et al., 1996).

Causative Hypotheses
Heart disease can impact CI through primary and secondary methods. Primary
methods include direct effects that heart disease can have on cognition (Bennett & Sauve,
2003). These direct effects include atherosclerosis, experiencing an MI, undergoing
corrective surgery, and having congestive heart failure. Secondary sources of impairment
can arise from treatment regimens themselves, such as the drugs used to treat heart
patients (Nykamp, Morgan, & Roland, 2009).
Several primary hypotheses have been proposed as to the causes of CI in heart
patients (Bennett & Sauve, 2003). These hypotheses include cerebral infarction due to
cardiac mural emboli and cerebral ischemia due to chronic or intermittent cerebral
hypoperfusion (Bennett & Sauve, 2003; Gruhn et al., 2001; Pullicino & Hart, 2001;
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Taylor & Stott, 2002), and both label ischemia as the main culprit. Non-ischemic
hypotheses include the effects of drugs used to treat heart patients (Nykamp, et al., 2009).
The cardiac mural emboli hypothesis, which is most applicable in patients with
heart failure, suggests that plaques from cardiac arteries may break off and become
lodged in the cerebrum, causing stroke or acute ischemia (Bennett & Sauve, 2003;
Pullicino & Hart, 2001). Any stroke that occurs in heart patients of any type is likely
cardioembolic due to left ventricle systolic dysfunction, which encourages thrombus
formation (Pullicino & Hart, 2001). CHF patients with impaired ejection fractions (often
described as below 40-50%) are most likely to form thrombi and have a subsequent
cerebral infarction (Beer et al., 2009; de Jonge et al., 2006; Moser, et al., 1999; Pullicino
& Hart, 2001).
The second hypothesis labels cerebral hypoperfusion as the main cause of
ischemia. In CAD patients, this can manifest from surgical blood loss and
hypoperfusion, ischemia due to an MI, or a combination of other health factors presurgery (Hogue, et al., 2006; Lal, 2007; Roine, et al., 1993). In CHF patients, a chronic
systolic dysfunction of the left ventricle reduces ejection fraction and heart efficiency,
causing a long-term reduction in cerebral blood flow (Gruhn, et al., 2001; Pullicino &
Hart, 2001). Though the length of time ischemia is present can vary between heart
patients, the cognitive deficits observed are similar in type and quality, with their
duration and severity correlated with the degree of hypoperfusion, as well as the presence
of CHF (Bennett & Sauve, 2003; Hogue, et al., 2006; Roine, et al., 1993).
A third hypothesis relating CI to heart patients focuses on the secondary effects of
pharmacological treatment. While the ischemic effects associated with heart disease and
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its various surgical interventions have been discussed, secondary effects from the
medications used to improve health outcomes may adversely affect a patient’s cognitive
abilities as well (Nykamp, et al., 2009). Because the cognitive effects seen from cardiac
drug use mimic those seen from ischemic factors, care must be taken to identify and
manage pharmacological factors in order to decrease patient morbidity (Bennett & Sauve,
2003; Nykamp, et al., 2009).

Affected Domains
Since both CAD and CHF are part of the larger umbrella of heart disease, they
can both affect cognition in similar ways (Roine, et al., 1993; Vogels, Scheltens, et al.,
2007). Because CHF can be thought of, in part, to be one end of a continuum that begins
with angina and other less severe CAD symptoms, the cognitive deficits observed in CHF
patients mimic those seen in CAD patients, but are both more pervasive and severe
(Bennett & Sauve, 2003; Vogels, Oosterman, et al., 2007; Vogels, Scheltens, et al.,
2007). While half of patients who experience an MI, CABG surgery, or other acute event
had no cognitive sequelae after one year, patients with CHF had more persistent and
chronic cognitive problems (Bennett & Sauve, 2003; Roine, et al., 1993; Savageau,
Stanton, Jenkins, & Frater, 1982), suggesting that chronic heart disease has a large
influence over a patient’s cognitive abilities. Cognitive deficits observed in heart patients
fall into several neuropsychological categories, including attention, verbal memory,
working memory, executive function, and psychomotor speed (Bauer & Pozehl, 2010;
Bennett & Sauve, 2003; Bennett, Sauve, & Shaw, 2005; Murkin, Newman, Stump, &
Blumenthal, 1995; Sauve, Lewis, Blankenbiller, Rickabaugh, & Pressler, 2009).
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Attention
Attention is defined as a concentration of mental activity (Matlin, 2002). It
generally relates to an organism’s ability to selectively focus its mental activity on a
specific stimulus (Matlin, 2002). Attention to a stimulus is critical for other functions
such as memory and language, mediates one’s ability to encode a memory or carry on a
conversation with a friend, and can be unconscious/reactive (bottom-up) or conscious
(top-down) (Leon-Carrion, 1997; Matlin, 2002). Anatomically, attention is not related to
any one specific cerebral structure, but depends on a complex network of systems to
operate (Leon-Carrion, 1997). This includes both posterior systems, which orient an
individual to external stimuli, and anterior systems, which orient an individual to
perceptions and meanings to guide action (Leon-Carrion, 1997).
Impaired attention is well-documented in heart patients (Bennett & Sauve, 2003;
Hammeke & Hastings, 1988; Rengo et al., 1995). Attention problems can be due to both
the direct effects of heart disease and other, related conditions such as hypertension
(Cherubini et al., 2007). Impairments have been noted for both simple (single stimulus)
and complex (several competing stimuli) tasks (Bennett & Sauve, 2003), although simple
attention is most related to cardiac predictors such as fibrillations and reductions in
ejection fraction. While multiple studies have found impaired attention for all heart
patients, there is some evidence that attention problems are more pronounced in patients
with CHF (Vogels, Oosterman, et al., 2007). This suggests that longer-term heart
disease, such as exhibited by CHF patients, is related to more significant deficits in
attention.
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Because attention modulates other cognitive functions, it has profound
implications for a patient’s general cognitive status and overall quality of life (Bennett, et
al., 2005). A patient who cannot attend to valuable health information will be unable to
later recall or implement this information. Because attention is closely related with and
modulates other cognitive functions such as memory, a patient with poor attention may
present with poor memory recall as a result of impaired attention processes (Vogels,
Oosterman, et al., 2007). In a disease like CAD or CHF, impaired attention can
additionally lead to higher morbidity (Stanek, et al., 2011).

Memory and Working Memory
Memory is defined as an organism’s ability to recall previous learned information,
and is intimately tied to learning (Eichenbaum, 2002). Memory can refer to declarative
or procedural types, which refer to whether something is explicit (such as a learned fact)
or implicit (such as a behavior or action). Neuropsychologically, memory is generally
associated with the semantic and episodic types, which are both components of
declarative memory and refer to memories of learned facts and past events, respectively
(Feinberg & Farah, 2003). The brain structure most often associated with learning and
recall is the hippocampus, a bi-lateral mesial temporal lobe structure that associates and
synthesizes current stimuli with previously learned information (Eichenbaum, 2002). In
this way, it associates and compares stimuli with cognitive maps or memories to integrate
new information into the memory system (Eichenbaum, 2002). The recall of this
information is also facilitated by the hippocampus, although old memories are able to be
recalled without its aid (Eichenbaum, 2002). Traditionally, the left hippocampus is most
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often associated with learning and memory for verbal information and the right for nonverbal or visuospatial information (Bennett & Sauve, 2003; Eichenbaum, 2002; Feinberg
& Farah, 2003).
Working memory is another type of memory that is generally associated with the
prefrontal cortex (Eichenbaum, 2002). In contrast to traditional, “long-term” memory,
working memory refers to the ability to temporarily hold information online while it is
manipulated or processed. After processing, it can be stored through the hippocampus
and other medial temporal structures, or outputted (Eichenbaum, 2002).
Learning and memory deficits are common in heart patients (Bennett, et al.,
2005). Deficits include the sub-domains of learning, working memory, verbal memory,
and visuospatial memory (Antonelli Incalzi et al., 2003; Beer, et al., 2009; Bennett, et al.,
2005; Hammeke & Hastings, 1988; Lim, Alexander, LaFleche, Schnyer, & Verfaellie,
2004). While both CAD and CHF patients often present with memory impairments, CHF
patients are more likely to have pervasive deficits that persist over time (Bennett &
Sauve, 2003; Lim, et al., 2004). CAD patients, conversely, are likely to experience a
recovery of memory abilities, although functional recovery is limited to the first three
months after an MI or surgery (Lim, et al., 2004). Among CHF patients, those with more
severe symptoms (NYHA class IV) do not demonstrate more pervasive deficits than
patients with less severe CHF (NYHA class II) (Antonelli Incalzi, et al., 2003).
CHF patients with memory impairments often possess bilateral mesial temporal
lobe atrophy on MRI, with more pronounced right-sided volume loss (Beer, et al., 2009).
The affected area includes the hippocampus, which is particularly sensitive to the
hypoxia seen in heart patients (Bennett & Sauve, 2003; Eichenbaum, 2002). This may

23

help explain why CHF patients present with more pervasive and long-lasting learning and
memory impairments compared to their CAD counterparts.
Functionally, heart patients with memory impairments may experience an
interference with rehabilitation and treatment regimens (Moser, et al., 1999; Vogels,
Oosterman, et al., 2007). However, given the transient nature of memory impairments in
recovered CAD and less-impaired CHF patients (NYHA class I), memory deficits may
not be significant enough to appreciably affect CR or other treatment programs (Grubb,
Simpson, & Fox, 2000). Rehabilitation programs that focus on repetition and memory
aids are more likely to overcome these obstacles, further making memory impairment
less of an issue (Grubb, et al., 2000). However, memory deficits, especially due to mesial
temporal lobe atrophy, remain serious problems for heart patients (Beer, et al., 2009;
Vogels, Oosterman, et al., 2007; Vogels, Scheltens, et al., 2007).

Executive Functioning
Executive functioning (EF) refers to the top-down processes that organize and
mediate other neuropsychological constructs, such as attention and memory (Feinberg &
Farah, 2003). Specifically, EF involves mental strategy, organization, cognitive
flexibility, response inhibition, the shifting of attention and mental set, and the ability to
abstract (Feinberg & Farah, 2003). A key component in EF is top-down processing, or
the ability of a neural network to guide behavior through internal states or intentions
(Miller & Cohen, 2001). Top-down processing incorporates internal representations or
goals in modulating behavior, and serves as a mechanism of cognitive control. EF is
mediated primarily by the fronto-striatial networks in the brain, which are responsible for
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the top-down control that influences and coordinates other neural networks, such as
memory (Feinberg & Farah, 2003).
Anatomically, there are several areas generally associated with executive
functioning. The pre-frontal cortex (PFC), part of the fronto-striatal network, plays a
primary role in executive functioning and cognitive control (Miller & Cohen, 2001). The
PFC’s ability to experientially modify its anatomy, as well as its numerous and diverse
inputs and projection pathways make it an ideal area to organize and synthesize
information, organize complex tasks, and shift mental set (Feinberg & Farah, 2003;
Miller & Cohen, 2001). Representations in this area have been noted to exert top-down
influence over other brain systems, so as to best delineate a pathway needed to perform a
specific task. Besides the PFC, the striatum and other basal ganglia structures are also
responsible for executive functioning and control (Kalat, 2004; Kropotov & Etlinger,
1999; Miller & Cohen, 2001). These structures are intimately connected with the PFC
through afferent and efferent connections, and mirror the functions of the PFC (Kalat,
2004). Specifically, basal ganglia structures are involved in planning, rule learning, and
organizing sequences of movements (Kalat, 2004). They also play a major role in
response inhibition and being able to actively decide which response is the most
appropriate for a given stimulus (Kropotov & Etlinger, 1999).
Executive deficits are commonly observed in heart patients (Kakos, et al., 2010;
Petrucci et al., 2009; Pressler, Kim, et al., 2010). Similar to other functional areas, EF
deficits are seen in both CAD and CHF patients (Lim, et al., 2004; Vogels, Oosterman, et
al., 2007). Patients with CAD appear to have variable EF deficits, with no persistent or
pervasive pattern of impairment (Lim, et al., 2004). In CHF patients, executive functions
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are more often impaired, with impairments evident in both CHF patients living
independently and those being seen for more severe physiological symptoms (Bauer &
Pozehl, 2010; Bennett, et al., 2005; Vogels, Oosterman, et al., 2007). This suggests that
EF, like memory, is impaired across the NYHA severity spectrum in CHF patients.
Heart patients with the neuroanatomical atrophy more often seen in CHF are more
likely to have EF impairments (Beer, et al., 2009). The most commonly observed areas
of anatomical volume loss include the medial temporal lobes bilaterally, which directly
affects memory (through hippocampal atrophy) but less directly influences EF.
However, imaging has also revealed periventricular and deep white matter
hyperintensities, which includes white matter pathways integral in the fronto-striatal
networks observed in EF (Beer, et al., 2009). The loss of afferent and efferent
connections, as well as general cerebral volume loss may help explain the executive
deficits commonly observed in heart patients.
Like other functional domains, impaired executive functioning has major
implications for health and disease morbidity (Kakos, et al., 2010). Because of the
inability to focus, plan, and mentally organize information, patients with EF impairments
are less likely to adhere to treatment regimens and display limited gains in cardiovascular
fitness and quality of life (Kakos, et al., 2010). This, in turn, leads to lower health
outcomes and little benefit from CR and other commonly used comprehensive treatment
programs. Thus, EF dysfunction reveals a serious and potentially less changeable set of
impairments that can directly impact health recovery.
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Psychomotor Speed
Psychomotor speed refers to the ability to rapidly and fluently perform physical
body motor movements with precision (McGrew, 2009). These movements, often
involving the fingers and hands, is largely independent of direct cognitive control
(McGrew, 2009). Domains including Speed of Limb Movement, or the ability to make
rapid discrete limb movements; Writing Speed Fluency, or the ability to correctly copy or
write words quickly; Speed of Articulation, or the ability to rapidly perform speech
articulations; and Movement Time, or the time taken to physically move a body part to
make a required movement all fall under the heading of psychomotor speed (McGrew,
2009). This ability is important for the quick and accurate automated abilities that are
important for numerous daily activities, such as typing, writing, and speaking.
Anatomically, psychomotor slowing (dysfunction) is associated with
periventricular white matter lesions immediately proximal to the lateral ventricles
(Hannesdottir et al., 2009; Tiemann, Penner, Haupts, Schlegel, & Calabrese, 2009). Of
particular association with psychomotor speed are the tracts that connect the frontal lobes
to other cortical and subcortical structures (Hannesdottir, et al., 2009), similar to those
used in the EF system. Lesions in other white matter tracts are less associated with
psychomotor dysfunction, suggesting that the performance of frontal periventricular
tracts are of specific importance (Hannesdottir, et al., 2009; Tiemann, Penner, et al.,
2009). Since demyelination or lesions in white matter affect its ability to quickly and
reliably carry action potentials, the association of psychomotor slowing with white matter
health is not surprising. Additionally, small lesions that are neurologically classified as
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“clinically silent” may result in selective neuropsychological deficits in domains like
psychomotor speed (Tiemann et al., 2009).
Like the other domains discussed, psychomotor slowing is common in heart
patients (Hoth, Poppas, Moser, Paul, & Cohen, 2008; Tiemann, Reidt, et al., 2009;
Vogels, Scheltens, et al., 2007). Psychomotor impairments are most common in CAD
patients that have had an MI or corrective surgery, as well as in CHF patients (Bauer et
al., 2011; Tiemann, Reidt, et al., 2009). Similar to other cognitive domains, CHF patients
tend to have a greater incidence of psychomotor impairment than their CAD counterparts,
with some studies suggesting a significant difference between CAD and CHF patients
(Hoth, et al., 2008). However, CAD patients that have more severe symptoms, including
MI, or those that have had surgical intervention – even less invasive interventions like
angioplasty – do have a higher rate of psychomotor impairment (Stanek, et al., 2011;
Tiemann, Reidt, et al., 2009), with deficits resolving in most patients by 6 months postsurgery (Hammeke & Hastings, 1988). The psychomotor improvement of heart patients
who underwent CR or a similar intervention did differ, however, with CAD patients
much more likely to demonstrate improvements in psychomotor functioning than their
CHF counterparts when encountering treatment (Bennett, et al., 2005; Stanek, et al.,
2011; Vogels, Scheltens, et al., 2007). Patients who have hypertension, which is often
associated with heart disease, tend to have greater psychomotor impairments, as
hypertension alone is often associated with psychomotor dysfunction and its addition to
heart disease pathology causes compiled impairment (Hannesdottir, et al., 2009).
Psychomotor impairment has major implications for morbidity and mortality in
heart patients (Pressler, Kim, et al., 2010). Although psychomotor speed is not directly
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associated with specific functional deficits, e.g. poor memory encoding with attention
impairments, it is related to a patient’s morbidity and mortality, as well as their quality of
life (Pressler, Kim, et al., 2010). The detrimental association between psychomotor
speed and health is particularly evident in CHF patients with low ejection fractions
(<40%). In this population, representative of the more severe end of the heart disease
spectrum, patients who died within twelve months had worse psychomotor abilities
compared with those who did not (Pressler, Kim, et al., 2010). This suggests that
psychomotor abilities tend to decrease significantly as one’s disease process becomes
more severe. Thus, psychomotor impairment serves as in indirect marker of disease
severity; although it may be relatively unchanged in less severe heart patients, those with
more critical symptoms demonstrate psychomotor impairments that are correlated with
their morbidity and mortality.

Predictors of Cognitive Status
The relationship of cognitive impairment to disease processes in heart patients can
be complex, with several domains related to cognitive status in heart patients. The
domains include variables associated with a patient’s health, cognitive reserve, and
affective functioning, and suggest a more complex causative model of cognitive
impairment than simple disease severity measures.

Health Predictors
Blood Pressure
Chronic high blood pressure, or hypertension, is a medical condition
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independently associated with impaired cognitive abilities (Cherubini, et al., 2007). It is
defined as having chronic high blood pressure above 140 systolic or 90 diastolic, and
affects more than half of those over 60 years of age (Chobanian et al., 2003). While
many persons with hypertension may live relatively symptom-free, those who poorly
manage their disease put themselves at risk for developing cognitive impairments
(Cherubini, et al., 2007). In non-heart patients, hypertension often affects cognition
through an increased risk of vascular dementia, characterized by small cerebral microbleeds that can affect one’s cognition (including memory), motor abilities, and
personality (Acanfora, et al., 1996; Cherubini, et al., 2007; Feinberg & Farah, 2003; van
Swieten, et al., 1991).
Hypertension is a major risk factor for the development of CAD and CHF (Croft
et al., 1999; Wynands, Sheridan, Batra, Palmer, & Shanks, 1970). Not only is
hypertension a risk factor for developing CHF, but it can put asymptomatic persons at a
greater risk for increased arterial atherosclerosis and future heart disease-related insults
and disease processes as well (Dzau, 1990; Kalay, et al., 2010). In CHF, hypertension
(along with CAD) is seen as a direct precursor, and can facilitate acceleration of disease
processes in non-CAD individuals (Bennett, et al., 2005). Because of its independent
association with cognitive deficits, as well as its intimate association with CHF, the
presence and degree of hypertension in heart patients can be seen as a predictive measure
of cognitive status and impairment.

Surgery History
Post-operative cognitive dysfunction (POCD) is known to result as a complication
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of major surgery (Ropacki, Bert, Ropacki, Rogers, & Stern, 2007). Cognitive
dysfunction can be particularly evident for those undergoing CABG and other heartrelated procedures (Ropacki, et al., 2007; Royter, N, & Russell, 2005; van Dijk et al.,
2000). Previous research has estimated that between 33 and 83% of patients undergoing
CABG and other heart procedures have cognitive dysfunction post-operatively, with
between 4 and 47% exhibiting neuropsychological deficits two months out, and up to
25% exhibiting deficits 6 months out (Newman et al., 2001; Ropacki, et al., 2007; Royter,
et al., 2005; Selnes, Goldsborough, Borowicz, & McKhann, 1999; Sun, Lindsay,
Monsein, Hill, & Corso, 2012; van Dijk, et al., 2000). These deficits may occur with or
without focal neurologic deficits (Sun, et al., 2012)
The etiology of such impairments is somewhat unclear, but are likely due to both
general surgical effects such as anesthesia and specific effects of cardiac surgery such as
the potential for cerebral embolisms, hypoperfusion, and the effects of perioperative
drugs (Newman, et al., 2001; Ropacki, et al., 2007; Royter, et al., 2005; Selnes, et al.,
1999; Sun, et al., 2012). Thus, while POCD can occur after any surgery, it is particularly
likely after cardiac surgery (Newman, et al., 2001). For these reasons, a patient’s surgery
history can affect his or her cognitive abilities. While recent surgeries are more likely to
produce POCD, there is some evidence that longer-term cognitive dysfunction can occur
post-surgery, particularly in patients more prone to stroke, dementia, or low cognitive
reserve (Ropacki, et al., 2007; Sun, et al., 2012).

Presence of CHF
While cognitive dysfunction is common to all types of heart patients, numerous
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studies have cited CHF patients as having the most severe cognitive symptoms (Beer, et
al., 2009; Bennett & Sauve, 2003; Hoth, et al., 2008; Lim, et al., 2004; Pullicino et al.,
2008; Rengo, et al., 1995; Vogels, Scheltens, et al., 2007). CHF often represents the
endpoint of CAD patients (Rengo, et al., 1996), and its presence thus represents a person
who has experienced heart disease processes for a long period of time. Additionally,
CHF is a disease characterized by chronic symptoms and disease processes, rather than
the more acute clinical manifestations seen in CAD patients. For these reasons, the
presence of CHF in CR patients can be seen as a predictor of worse cognitive abilities
compared to those not diagnosed with congestive heart failure.

Cognitive Predictors
The concept of cognitive reserve is used to explain the dissociation between an
individual’s pathology and their cognitive impairment (Stern, 2009; Vemuri et al., 2011).
That is, patients with higher levels of cognitive reserve have a greater capacity to cope
with neurological insults than those with lower levels of cognitive reserve, explaining
why cognitive decline is initiated at different times in relation to the onset of pathology
(Vemuri, et al., 2011). While all patients with a chronic disease process such as CHF or
dementia will eventually end up at the same level of impairment, those with higher
cognitive reserve have a later point of cognitive decline, displaying a later onset of
cognitive symptoms than those with low cognitive reserve (Stern, 2009). The nature of
this relationship does, however, specify that those with high cognitive reserve will
display a steeper rate of decline once cognitive symptoms are evident (Ropacki, et al.,
2007; Stern, 2002, 2009).
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Cognitive reserve is an active model, suggesting that the brain actively copes with
pathology using pre-existing cognitive processes or enlisting compensatory strategies
(Stern, 2002, 2009). An individual’s neural reserve is thought to be mediated by
differences in neural efficiency as well as flexibility and greater capacity, as measured by
epidemiological research and imagining studies examining cerebral blood flow (Stern,
2009). An individual’s neural compensation refers to the ability to compensate for
pathological disruption by employing brain structures or networks not normally used for
those functions, helping to sustain or even boost cognitive performance (Stern, 2009).
Thus, cognitive reserve is not a fixed cutoff, but focuses on processes that allow a patient
to sustain brain damage yet maintain function. Anatomically, cognitive reserve is
mediated less by specific brain structures, and more by higher-level neural networks in a
top-down approach that tend to be faster and more flexible in certain individuals (Stern,
2009)
The measures that are typically associated with cognitive reserve are variables of
lifetime experience and socioeconomic status (SES), such as educational attainment,
income, or an individual’s Intelligence Quotient (IQ) (Manly, Touradji, Tang, & Stern,
2003; Ropacki, et al., 2007; Stern, 2002, 2009). These variables have been found to be
highly correlated with an individual’s level of cognitive reserve; higher IQ and greater
educational attainment are generally associated with a later point of cognitive decline
(Stern, 2009). With regards to IQ, an individual’s premorbid IQ, the term given to more
stable abilities such as vocabulary and word reading which are less likely to be impacted
by neurological insults or pathology, is often utilized as a predictor of cognitive reserve
(Albert & Teresi, 1999; Green et al., 2008; Stern, 2009).
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There are relatively little data on cognitive reserve in heart patients, with most
research examining Alzheimer’s Dementia (AD) and traumatic brain injury (TBI)
patients (Stern, 2002, 2009; Ylioja, Hanks, Baird, & Millis, 2010). The few studies that
do relate heart disease and cognitive reserve have suggested that, similar to AD and TBI
patients, heart patients with higher levels of reserve show less cognitive impairment when
controlling for the severity of disease process (Singh-Manoux et al., 2008). Specifically,
there is little association between CAD inflammatory processes and cognition in high
SES patients compared with their low SES counterparts, suggesting cognitive reserve
processes help high-SES CAD patients stave off cognitive impairment (Singh-Manoux, et
al., 2008; Singh-Manoux et al., 2009). CAD patients with high cognitive reserve do,
however, show a sharp decline in functioning after CABG surgery relative to their lowreserve counterparts, suggesting a possible “threshold effect,” where high-reserve
individuals surpass their ability to cognitively cope and decline at a relatively steep rate
to eventually match the abilities of low-reserve patients (Ropacki, et al., 2007; Stern,
2009). These findings, and the fact that an association between heart disease and
cognition is dependent on reserve correlates such as SES (Singh-Manoux, et al., 2009)
suggest that the mechanisms of cognitive reserve are as important in heart patients as they
are in their AD and TBI counterparts.

Affective Predictors
Affective variables refer to psychological, psychosocial, and mood-related factors
that can impact one’s health. While traditionally not part of the medical treatment model,
variables like depression, anxiety, and stress/distress are increasingly being studied in
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conjunction with heart failure (Rengo, et al., 1995). These factors can have major
implications for health, relating to both morbidity and mortality.

Depression
Depression is common in medically ill patients, and has major ramifications for
disease morbidity and mortality (Carney & Freedland, 2009; Krishnan, 2005; Naqvi,
Naqvi, & Merz, 2005). The presence of major depression concurrent with a medical
illness is more likely to lead to reduced quality of life and can increase the risk of
mortality (Krishnan, 2005). While this depression is often treatable, its incidence is
commonly overlooked in favor of a more singular focus on a patient’s physical symptoms
(Krishnan, 2005; Thombs et al., 2008). The lack of screening for depression in medically
ill patients suggests that screening for and treating this debilitating disease could improve
health outcomes and quality of life (Krishnan, 2005; Thombs, et al., 2008). A
combination of therapy and medication, similar to the suggested treatment regimen in
non-ill individuals, has been found to be useful in treating patients with medical
conditions (Krishnan, 2005; Thombs, et al., 2008).
Because depression is common in older individuals, a disease process like heart
disease that often strikes older individuals is characterized by a high incidence of
depression (Freedland et al., 2009; Kent & Shapiro, 2009; Thombs, et al., 2008). In
patients with acute CAD, such as those who have recently experienced an MI, a diagnosis
of major depression is related with double the risk of cardiac death, especially in patients
who have depression that is difficult to treat (Carney & Freedland, 2009; Kent & Shapiro,
2009; Naqvi, et al., 2005; van den Brink et al., 2002). Similarly, in patients with more
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chronic heart disease processes like CHF, the presence of depression can have a major
impact on quality of life, leading to a greater incidence of disability and death, possibly
incurring a similar double risk of death as seen in CAD patients (Bennett & Sauve, 2003;
Kent & Shapiro, 2009). While a combination therapy of cognitive behavioral therapy
(CBT) and medication does little to affect primary cardiac measures, these treatment
modalities are extremely useful in improving a patient’s quality of life, which has
secondary benefits for a reduced risk of mortality (Freedland, et al., 2009; Naqvi, et al.,
2005). Thus, depression mediates the relationship between a patient’s level of illness and
their morbidity and mortality.
In contrast to depression’s clear effects on health and mortality, its relationship to
neuropsychological functioning in heart patients is less clear (Bennett & Sauve, 2003;
Sauve, et al., 2009). While depression is commonly associated with cognitive difficulties
such as attention deficits, verbal and visual learning and memory impairments, slowed
processing speed, and executive dysfunction, there is conflicting evidence for cognitive
impairment in heart patients due to depression (Baune et al., 2010; Beer, et al., 2009;
Delgado & Schillerstrom, 2009; Vogels, Scheltens, et al., 2007). While some studies
have found no cognitive differences due to depression, others have reported negative
effects on a patient’s cognitive functioning due to depression (Bennett & Sauve, 2003;
Vogels, Scheltens, et al., 2007). Because the relationship of depression to a heart
patient’s overall health is more complex than a simple causal relationship, it perhaps also
serves as a mediator of cognitive status in medical patients with impaired cognitive
status.
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Anxiety
Like depression, heart patients often have a higher incidence of anxiety than
healthy controls, with some studies suggesting double the incidence rate over population
means (Kent & Shapiro, 2009; D. K. Moser et al., 2007). The presence of anxiety is
similarly associated with higher disease morbidity and mortality (Bennett & Sauve, 2003;
Bennett, et al., 2005; Kent & Shapiro, 2009). While depression is seen in heart patients
mostly as a result of the disease pathology, anxiety is often additionally observed as a risk
factor for the initial development of heart disease, with more anxious individuals being at
a higher risk of cardiac-related death (Kent & Shapiro, 2009). Anxiety as a predisposing
factor is most often associated with sudden cardiac death, rather than non-fatal MI. Postevent anxiety can also impact health, with anxious heart patients undergoing treatment
being more at risk for serious in-hospital complications and worse long-term disease
morbidity than those that do not have anxiety (Kent & Shapiro, 2009; D. K. Moser, et al.,
2007). However, the presence of both depression and anxiety do not confer added risk
over the presence of one of these affective symptoms (Kent & Shapiro, 2009).
While anxiety is not as classically associated with cognitive impairment as
depression, there is some evidence that anxiety is related to impaired cognition in heart
patients, conferring a risk independent of depression (Vogels, Scheltens, et al., 2007).
However, other studies have found no significant differences in cognitive outcomes due
to anxiety, even in samples with a higher rate of anxiety than controls (Bennett & Sauve,
2003; Grubb, et al., 2000; Sauve, et al., 2009). Because of anxiety’s complex
relationship with heart disease, serving as both a risk factor for initial symptom
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development and a mediator of morbidity and quality of life, its status as an established
risk factor for cognitive impairment in this population is not clear.

Psychosocial Stress
Stress has long been studied in conjunction with heart disease. The classic “type
A” personality, characterized by individuals that are aggressive, high-strung, hurried, and
competitive, has classically been viewed as a risk factor for developing heart disease
(Kent & Shapiro, 2009), although the data are somewhat controversial. While the
presence or absence of a “type A” personality risk factor may be debated, CAD patients
who have experienced an MI have significantly higher work, home, financial and general
stress, as well as a greater number of stressful life events (Kent & Shapiro, 2009).
Similarly, stress has a negative impact on overall quality of life and mortality in heart
patients, similar to the impacts of depression and anxiety (Kent & Shapiro, 2009; Vogels,
Scheltens, et al., 2007). Some patients with impaired ejection fraction or a history of MI
who undergo surgery even develop Posttraumatic Stress Disorder (PTSD) symptoms,
leading to a two- to four-fold increase in the risk of mortality (Kent & Shapiro, 2009).
While psychosocial stress can be a primary contributor in the development and
maintenance of heart disease processes, it is also related to the formation of depression,
especially when medical illnesses are interpreted as stressful (Freedland, et al., 2009).
Thus, stress can influence health in a number of ways and represents both a cause and
effect of heart disease processes.
The data on psychosocial stress and cognitive functioning in heart patients are
quite limited (Pressler, 2008). While the impact of stress on health is clear, its impact on
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cognitive abilities is less well known. Because stress is related to depression and anxiety,
it may affect cognition in a mediation model with depression and anxiety serving as
mediating variables (Alagiakrishnan, McCracken, & Feldman, 2006; Kent & Shapiro,
2009; Vogels, Scheltens, et al., 2007). Alternatively, the relationship between stress and
cognitive ability in heart patients may mirror that seen between stress and AD patients,
who experience exacerbated cognitive decline as a result of vascular disease processes
(Alagiakrishnan, et al., 2006; Cherubini, et al., 2007). Whatever the relationship, it is
clear that stress can impact health directly, and may be a factor in cognitive impairment
as well.

39

CHAPTER THREE
OBJECTIVES AND HYPOTHESES

While the presence of cognitive impairments in heart patients is well known, the
degree to which health, cognitive, and affective factors influence these impairments and
heart patients’ cognitive abilities is relatively unknown (Bennett & Sauve, 2003; Vogels,
Scheltens, et al., 2007). While individual factors (such as IQ or depression) have been
shown to affect patients’ cognitive abilities, the presence of different types of predictors
in a hierarchical model provides the ability to discern which elements provide the most
benefit or harm to heart patients’ cognitive functioning. This study examines these
relationships through two separate, but related, aims.
The first aim of this study is to characterize which factors best predict the
cognitive functioning of heart patients. This aim was addressed through hierarchical
linear regression models, more fully described in the methods section.
Aim 1 consists of 6 hypotheses, one for each domain identified as affected in
heart patients (attention, immediate memory, delayed memory, working memory,
executive functioning, and psychomotor speed) (Bauer & Pozehl, 2010; Bennett &
Sauve, 2003; Bennett, et al., 2005; Vogels, Scheltens, et al., 2007). For each hypothesis
it is hypothesized that both medical and affective predictors as a group will negatively
affect cognitive functioning, and that variables associated with higher cognitive reserve
will predict better cognitive functioning for those without CHF. Furthermore, it is
hypothesized that the presence of CHF and hypertension, as well as more numerous
surgeries, higher depression, higher anxiety, and greater stress will negatively impact
cognitive functioning, while higher levels of education and premorbid IQ will positively
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impact cognitive functioning. Finally, it is hypothesized that generally non-impaired
cognitive abilities, such as visuospatial ability, will not be predicted by the hierarchical
model. This hypothesis will be tested using a 7th regression analysis.
The second aim of this study is to determine which cognitive factors predict a
patient’s enrollment in a cardiac rehabilitation program. Specifically, this aim examined
potential neuropsychological explanations for the choice to enroll or not enroll in a
rehabilitation program. This aim was addressed through a hierarchical logistic regression
model.
Aim 2 consists of a single hypothesis. It is hypothesized that both cognitive
reserve (education, IQ) and current cognitive ability (overall cognitive ability, working
memory, executive functioning, and psychomotor speed) will impact a person’s
likelihood of choosing to enroll in cardiac rehabilitation. Furthermore, it is hypothesized
that both variables related to cognitive reserve variables and all four current cognitive
status variables will serve as individual predictors, which higher levels of reserve and
cognitive ability predicting higher involvement in cardiac rehabilitation programs.
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CHAPTER FOUR
METHODS

Participants
The participants that were used for this study are two groups of patients. The first
sample (N=60) contains patients who attend the cardiac rehabilitation program at Loma
Linda University Medical Center (LLUMC). These individuals ranged in age from 23-93
years (Mean=61.38, SD=12.82, 65% male), and all were referred by their physician for
rehabilitation with the goal of improving their cardiac health through the comprehensive
program provided by CR. All patients have some degree of heart disease, hence their
referral to CR, although their exact diagnoses differ (e.g., CHF, MI, CABG surgery, etc.).
All participant data were gleaned from baseline neuropsychological assessments that are
done clinically to inform patient care as part of the CR intake examination process. Thus,
this study looked not at the treatment effects of CR, but simply used this population
because of its heterogeneous heart disease population. Obtaining participant data when
patients first come to CR (before any treatment) served to ameliorate any potential
treatment effects.
The second sample (N=14) consists of control patients who did not elect to
participate in cardiac rehabilitation. These individuals ranged in age from 39-87 years
(Mean=66.82, SD=15.03, 64% male). These patients had similar demographics to the
CR sample, with the exception of a higher rate of CHF, and attend the LLUMC Heart
Center for outpatient care. Control patients were tested on a voluntary basis in
conjunction with a visit to their care provider.
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Materials
Independent Variables/Predictors
Materials for this study included a demographic questionnaire, a standard
cognitive measure, and a medical chart review to glean information related to potential
predictors of cognitive status. These items served as the independent variables and
predictors of cognitive status. The specific predictors used included: presence of
hypertension, presence of CHF, and surgery history (medical predictors); education and
premorbid intelligence (cognitive reserve); and level of depression, anxiety, and
psychosocial stress (affective predictors).

Medical Predictors
Predictors in the medical domain included the presence of hypertension, the
presence of CHF, and surgery history. These variables were gleaned using a
demographic questionnaire. The presence of hypertension and CHF were obtained
through interview questions using the demographics questionnaire, and corroborated with
a medical chart review. Surgery history was gleaned through a medical chart review, and
was defined as the total number of past surgeries. Due to record keeping practices, it was
not possible to examine or delineate surgery type.

Cognitive Reserve
Predictors related to cognitive reserve included education and premorbid
intelligence. Education was measured using the demographic questionnaire self-report,
and was expressed in level of education achieved via a seven-point likert scale.
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Educational categories included less than high school, high school/GED, some college,
associates degree/technical school, bachelor’s degree, master’s degree, and doctoral
degree. Patients’ premorbid intelligence, which represents their intellectual ability apart
from and before the onset of any pathology that could affect their functioning, was
measured using the Wechsler Test of Adult Reading (WTAR) (Wechsler, 2001). This
measure is designed to provide an intelligence estimate for a patient’s level of
functioning before any disease pathology, including heart disease and related medical
diseases. It provides a standard score estimate of a patient’s full-scale IQ (FSIQ), which
is indicative of their overall cognitive abilities (Wechsler, 2001).

Affective Predictors
Affective predictors included depression, anxiety, and psychosocial stress
measures which were all administered in a short self-report battery. Depression was
measured using the Patient Health Questionnaire 9 (PHQ-9) (Kroenke, Spitzer, &
Williams, 2001). This measure consists of nine items on a four-point likert scale, with a
tenth item measuring symptom impact on daily functioning. Unlike other depression
measures, the PHQ-9 is designed for medical patients in primary care settings and is
useful for patients of all ages and medical diagnoses, including heart disease (Kroenke, et
al., 2001). Although it is half the length of other depression screeners, it possesses
sufficient sensitivity and specificity for identifying and diagnosing depression,
particularly in the medical population that will be examined in this study (Kroenke, et al.,
2001). Inter-rate reliability of the normative sample was 0.84; internal consistency
(Cronbach’s α) for the present study was 0.90.
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Anxiety was measured using the Generalized Anxiety Disorder 7 (GAD-7)
questionnaire (Spitzer, Kroenke, Williams, & Lowe, 2006). This measure consists of
seven items on a four-point likert scale, with an eighth item measuring symptom impact
on daily functioning. The GAD-7, like the PHQ-9, was designed for and validated with
medical patients in primary care settings. Although it focuses primarily on symptoms of
Generalized Anxiety Disorder (GAD), it possesses sufficient sensitivity (89%) and
specificity (82%), and was validated in a diverse range of medical settings with a wide
age range (Spitzer, et al., 2006). Internal consistency, measured using Cronbach’s α, was
0.92 for the normative sample and 0.91 for the present study.
Psychosocial stress was measured using the Perceived Stress Scale (PSS), which
measures patients’ perceived levels of stress (Cohen, Kamarck, & Mermelstein, 1983).
This scale directly measures how stressful an individual perceives his or her life to be,
and is highly correlated with stressful life events, depression, physical symptoms,
anxiety, and use of primary care services (Cohen, et al., 1983). The original scale
consisted of fourteen items on a four-point likert scale; the present study used an
empirically-validated truncated version consisting of four items, also on a four-point
likert scale. Like the other affective measures, this scale was developed and validated
with a wide group of individuals, including patients receiving medical treatment. It is
useful for a wide range of ages and is valid for use will all individuals, including heart
patients (Cohen, et al., 1983). Internal consistency, measured using Cronbach’s α, was
0.85 for the normative sample and 0.10 for the present study.
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Dependent Variables
Patients’ cognitive abilities served as the dependent variables and were tested
primarily using a full administration of the Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS) cognitive battery (Randolph, 1998), which serves
as a general purpose cognitive screener (Silverberg, Wertheimer, & Fichtenberg, 2007).
This battery has two alternate forms (A and B), which can aid in tracking changes over
time, although only one timepoint will be used for this study. To best capture the
hypothesized cognitive domains, several supplementary tests were used in addition to the
RBANS. These include digits backward from the Wechsler Adult Intelligence Scale
(WAIS) III and IV (Wechsler, 1997, 2008), FAS and CFL verbal fluency measures
(Bechtoldt, Benton, & Fogel, 1962; Benton, 1969; Fogel, 1962), and Trail Making from
the Delis-Kaplan Executive Function System (D-KEFS) (Delis, Kaplan, & Kramer,
2001). The use of both RBANS forms, as well as two digits backwards tasks (WAIS III
and IV) and two fluency measures allows for future research to track changes over time,
and will pair with other studies that will use the alternate forms to assess change at a later
timepoint.
The RBANS battery was chosen for its utility as a cognitive screener, providing a
reasonably complete neuropsychological profile in a brief amount of time (Bauer &
Pozehl, 2010; Randolph, 1998). It provides normative data for individuals ages 20-89
years of age with regards to their total cognitive abilities, as well as across 5 subdomains: Immediate memory, delayed memory, attention, language, and visuospatial
abilities (Randolph, 1998). Three out of these five domains relate to areas of impairment
seen in heart patients (excepting language and visuospatial abilities), but a full protocol is
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necessary to get a measure of overall functioning, as well as to adhere to standardized
protocol for valid administration (Randolph, 1998; Randolph, Tierney, Mohr, & Chase,
1998). A “Total Index Score” is tabulated that will serve as a predictor for Aim 2.
Since heart disease is most common in individuals older than 55, particular care
was taken to ensure the RBANS’ utility with this age group before including it in the
present study. The RBANS manual provides normative, standardized data in decadeincrements up to age 89. Subsequent studies examining the battery’s utility with older
adults have found it to be of clinical use with this age group, and it is sensitive enough to
detect pathological changes in cognitive functioning (Duff et al., 2005; Randolph, et al.,
1998). Additional validity testing has suggested that refined age and education-corrected
base rates could enhance the test’s sensitivity for older adults, especially when examining
individual subtests (Duff et al., 2003; Patton et al., 2006). However, while these
corrections are of definite utility for individuals greater than 80 years of age, corrections
for younger individuals may be of less clinical utility (Gontkovsky, Mold, & Beatty,
2002). Because of conflicting evidence regarding corrected norms and the utility of
norms corrections being most evident when examining individual subtests, the standard,
normative data from the RBANS manual was used for this study.
Of equal importance to the RBANS utility with adults older than 55 is its use for
patients with heart disease. While the RBANS manual details its use in medical settings,
there are few published studies which describe using it with heart patients in a medical
setting specifically (Randolph, 1998). Research that does exist suggests that the RBANS
is useful with heart patients, and is sensitive enough to detect impairments with this
population (Bauer & Pozehl, 2010; Moser et al., 2004; D. J. Moser et al., 2007). This
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includes individuals with a history of CHF, as well as those with CAD, and suggests that
the RBANS is useful even for detecting cognitive changes correlated with pre-CAD
vascular changes (Moser, et al., 2004; D. J. Moser, et al., 2007).

Attention
One cognitive domain that was examined is attention. Attention was measured
using the “attention” index on the RBANS (Randolph, 1998). This index contains two
subtests, a digit span forward test and a digit symbol test, both similar to those used on
the WAIS intelligence measures (Randolph, et al., 1998; Smith, 1973; Wechsler, 1987).
On the digit span test, patients were asked to repeat a series of numbers of increasing
length, and are required to sustain attention in order to track the strings of digits. The
digit symbol test consists of arbitrary symbols associated with numbers in a key. Below
the key are numerous symbols with no numbers; patients were asked to match the correct
numbers with their appropriate symbols as quickly as possible, with a test length of 90
seconds.
These subtests are classically associated with, and valid for, measuring attention
(Putzke, Williams, Rayburn, Kirklin, & Boll, 1998; Smith, 1973; Turner & Gilliland,
1977), and have long been used as attention correlates. Patients who are administered the
RBANS had their attention index score calculated using normative data from the RBANS
manual. This data provided a patient’s normalized standard score (Mean=100, Std.
Dev.=15).
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Memory
Another cognitive domain that was examined is memory. Memory was measured
using several measures and indices, divided by its relevant domains. These domains
were chosen because of identified areas of impairment in heart patients (Bauer & Pozehl,
2010; Bennett & Sauve, 2003; Vogels, Scheltens, et al., 2007).

Immediate Memory
The sub-domain of immediate memory was measured using the “immediate
memory” index from the RBANS (Randolph, 1998). This index contains two subtests, a
list learning task and a story memory task, both of which test immediate verbal memory
(Randolph, 1998; Randolph, et al., 1998). Visuospatial/non-verbal memory, classically
seen as the complement to verbal memory, will also be gleaned through the full RBANS
administration. Given the lack of non-verbal deficits in heart patients, visuospatial ability
is not a theoretical focus of this study (Bauer & Pozehl, 2010; Bennett, et al., 2005).
However, by briefly analyzing and showing no differences in this domain, the results of
this study can be further validated.
On the list learning test, patients were presented with 10 unrelated words at a pace
of 1 every 1.5 seconds. They were then asked to repeat as many of these words as
possible. There are four learning trials for this test, which are summed to provide an
additive score of a patient’s ability to recall unrelated words with no time delay. For the
story memory test, patients were read a brief story at a pace slower than normal. They
were then be asked to recall as much of this story as possible. Each patient had two
attempts at hearing and recalling the story, with an additive score from both trials
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representative of a patient’s ability to recall semantically-related verbal information with
no delay.
Tests such as list and story memory tasks are often used as correlates of
immediate memory (Randolph, 1998). Measures such as the California Verbal Learning
Test (CVLT) and the logical memory subtest from the Wechsler Memory System (WMS)
are commonly used to test immediate verbal memory for unrelated and semanticallyrelated verbal information, respectively, and are very similar to their RBANS
counterparts (Delis, Kramer, Kaplan, & Ober, 2000; Randolph, 1998; Randolph, et al.,
1998; Wechsler, 2009). As with other domains, each patient’s immediate memory index
score was calculated using normative data from the RBANS manual. A normative
comparison of the two subtests yielded an immediate memory standard score, which will
allow for calculation of the changeability of memory compared with independent
predictors, as well as whether or not a patient is impaired in this area.

Delayed Memory
The sub-domain of delayed memory was measured using the “delayed memory”
index from the RBANS. This index was calculated using the same list learning and story
memory tasks from the immediate memory index, the difference being that delayed
memory looks at retention of this previously learned content after about a 15-20 minute
delay (Randolph, 1998). For the list learning task, patients were asked to recall words
learned during the four acquisition/immediate memory trials. They were also asked to
recognize which words were on the list in a forced-choice modality, which can assist in
the recall of learned information that cannot be spontaneously remembered (Delis, et al.,
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2000; Randolph, 1998). For the story memory component, patients were asked to simply
recall as much of the semantically-related story information as is possible.
The delayed memory index also includes a task of non-verbal/visuospatial
information, where a patient was asked to draw a complex figure that was previously
administered. Although immediate visuospatial ability was used as a null hypothesis for
this study, given the lack of evidence of involvement of these abilities in heart patients
(Bauer & Pozehl, 2010), the delayed memory index as a whole was used. A heart
patient’s score on the entire delayed memory index has shown to be impaired, although
this could be driven primarily by the verbal component (Bauer & Pozehl, 2010).
Regardless, the delayed memory index computes delayed memory as a composite of
verbal/non-verbal memory, and was used in its entirety to best mirror previous findings.
Delayed memory tasks similar to those utilized by the RBANS are often used as
correlates of memory retention and delayed memory, and reflect the delayed memory
portions of the CVLT and Logical Memory, both classically used to test memory (Delis,
et al., 2000; Randolph, 1998; Wechsler, 2009). Delayed memory tasks serve as
complements to the immediate memory portions, and provide information about a
patient’s ability to retain information over a period of time (Randolph, 1998). The nonverbal/visuospatial retention portion of the RBANS delayed memory index is similar to a
classically used test of non-verbal retention, the Rey-Osterreith Complex Figure Test
(RCFT) (Meyers & Meyers, 1995; Osterrieth, 1944; Rey, 1941). As with other domains,
the non-contextual list, semantically-related story, forced choice list recognition, and
figure recall subtests were used to calculate the delayed memory index, which yielded a
standard score useful for testing patient’s abilities and the presence of impairment.
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Working Memory
Working memory was measured using the digit span backwards test from the
WAIS-III and –IV (Wechsler, 1997, 2008). This test, which involves asking patients to
listen to a digit string of increasing length and repeat it backwards, has long been
associated with working memory due to the necessity to mentally retain, briefly hold, and
manipulate the digits before repeating them backwards (Reynolds, 1997; Wechsler,
2008). The differences in utilized mental processes between the forward (attention) and
backwards (working memory) digit span tasks are so great that they possess adequate
clinical utility when used on their own, rather than combining them into one overall
“digit span” measure (Reynolds, 1997). Like the digits forward task, digits backward is
useful for patients of all ages and diagnoses as a working memory correlate (Wechsler,
1997, 2008).
Patients administered digit span backwards were asked to repeat backwards a
digit string of increasing length. They received one point for every span repeated
correctly, which is summated to give a total score. The task was discontinued when
patients get both strings of the same length incorrect. The total score was then
normalized into a scaled score (Mean=10, SD=3), which can be directly compared with
other normalized scores to test the relationship of predictors to working memory.

Executive Functioning
The domain of executive functioning was assessed using several different
measures. These measures include the verbal fluency measures CFL/FAS as well as the
Trail Making test from the D-KEFS (Bechtoldt, et al., 1962; Benton, 1969; Delis, et al.,
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2001; Ruff, Light, Parker, & Levin, 1996). On the verbal fluency task, patients were
asked to think of as many words that start with a specific letter as possible within 60
seconds. These letters will either be C, F, and L; or F, A, and S. A patient’s summed
number of responses for all three letters was then compared with normative data to yield
a z-score that enabled comparisons similar to other cognitive domains (Mitrushina,
Boone, Razani, & D'Elia, 2005; Ruff, et al., 1996; Strauss, Sherman, & Spreen, 2006).
On the Trail Making test, patients were administered five conditions, although only the
fourth is pertinent to executive functioning. The first three conditions, which acclimate
the patient to the test, included a visual cancellation task marking all of the “3’s” on a
page, a number sequencing task connecting sequential numbers with a line, and a letter
sequencing task connecting sequential letters with a line. The primary task of interest is
the fourth condition, which had subjects switch back and forth between connecting
numbers and letters in sequence (Delis, et al., 2001). The time it took to complete this
sequencing task was recorded as the dependent variable, and converted to a scaled score
for analysis. The fifth condition was a motor speed task relevant to psychomotor speed.
Verbal fluency tasks, similar to the FAS and CFL tasks used for this study, were
originally developed as brief measures to help diagnose aphasia (Bechtoldt, et al., 1962;
Benton, 1969; Fogel, 1962; Ruff, et al., 1996). Regardless of the letters used (FAS, CFL,
etc.), verbal fluency instruments have classically been viewed and used as measures of
executive functioning, specifically relating to the organization and top-down processing
mediated by the prefrontal cortex (Mitrushina, et al., 2005). Similar to other tests in this
study, verbal fluency measures are useful with patients of all ages, including those with
medical diagnoses (Mitrushina, et al., 2005). There is also considerable evidence of their
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utility with patients of varying educational, SES, and intellectual backgrounds, making
these tests and their corresponding normative data valid for all patients who speak
English (Mitrushina, et al., 2005; Ruff, et al., 1996).
The fourth condition of the D-KEFS Trail Making test, used as one of two
executive function measures for this study, is very similar to the classic Trail Making
Test part B, which was originally developed by the Army in World War II and later
incorporated in standard neuropsychological batteries (Army Individual Test Battery
Manual of Directions and Scoring, 1944; Brown & Partington, 1942; Delis, et al., 2001;
Partington & Leiter, 1949; Reitan, 1955). This condition is firstly a test of cognitive
flexibility, which is a classical component of executive functioning as it is required for
higher-level skills such as divided attention and multitasking (Delis, et al., 2001).
Furthermore, this condition is useful for testing individuals of all ages and diagnoses, and
is highly sensitive to cognitive impairment. Finally, Trail Making tests such as that found
on the D-KEFS are often used with older adults, including those with medical conditions
(Mitrushina, et al., 2005).
For the purpose of analysis, both executive measures were collapsed into an
executive composite score. This was done by converting each subject’s score on both
measures to a z-score using normative data for each measure. The z-scores were then
averaged to obtain a composite score.

Psychomotor Speed
The domain of psychomotor speed was measured using condition five (motor
speed) of the D-KEFS Trail Making test (Delis, et al., 2001). For the motor speed
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subtest, patients were asked to connect empty circles following a dotted line as quickly as
possible. Although the accuracy of movements is important, the overall speed at which a
patient can connect the circles is the primary variable (Delis, et al., 2001).
Trail-making tests, such as the trails test from the D-KEFS battery, are often
associated with psychomotor speed (Bauer & Pozehl, 2010; Mitrushina, et al., 2005).
This is because the ability to quickly and skillfully complete the test has a strong motor
component that works synergistically with executive and other abilities (Delis, et al.,
2001; Mitrushina, et al., 2005). Although relatively new, the D-KEFS trails test
incorporates a pure “motor speed” condition (condition 5) which will be used for this
study, designed to get an essential measurement of a patient’s psychomotor abilities
without the added cognitive components present in other trails modalities (Delis, et al.,
2001). Similar to other measures, a patient’s total time spent completing the motor speed
condition was converted into a standardized scale score for comparison and analysis.

Design
Aim 1 of this study examined the effects that independent predictors across three
domains (medical, cognitive reserve, affective) have on heart patients’ cognitive
functioning. A hierarchical linear regression was used for each cognitive domain, with
predictors grouped into three levels based on their type. Medical predictors populated
level one, cognitive predictors level two, and affective predictors level three. Only CR
patients were used for this aim. This was due to the fact that the majority of control
patients had a CHF diagnosis, which would have biased the results of the regression
analyses for Aim 1.
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Aim 2 of this study examines the effects that cognitive variables have on a
person’s decision to voluntarily enroll in a cardiac rehabilitation program. Both the
rehabilitation and control samples were used for this aim. A single hierarchical logistic
regression was used, with the first level containing cognitive reserve variables and the
second including current cognitive ability variables.

Procedure
Participants for this study were recruited from cardiac patients attending CR or
patients who had chosen to not attend a rehabilitation program. All patients attending CR
programs receive a brief neuropsychological evaluation to aid in treatment and planning,
and participants were gleaned from this group. Patients entering CR sign a waiver upon
beginning CR that allows their de-identified data to be used for research purposes, so no
formal informed consent process was needed.
Patients were tested clinically as part of the standard intake procedure during their
first week attending CR, before the bulk of interventions have started. This minimized
any benefits patients may receive from CR treatments. Patients were given a clinical
evaluation, consisting of a demographic questionnaire, a full RBANS battery (A or B),
CFL/FAS verbal fluency, digits backwards from the WAIS III or IV, and trails from the
D-KEFS. The use of both RBANS batteries, as well as two verbal fluency and digit span
backwards tasks is for clinical purposes, with the aim to track patients’ cognitive progress
following CR using comparable measures. Only one timepoint (initial intake) was
utilized for this study, with patients randomly assigned to CFL or FAS, WAIS III or IV
digits backwards, and RBANS A or B. Following the neuropsychological measures, a
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self-report battery was administered that captures data relating to patients’ depression,
anxiety, stress, and other affective variables. All data for this study were gleaned from
these clinical evaluations.
Non-rehabilitation control patients were recruited from a list of patients attending
the outpatient heart failure clinic at the Loma Linda University Medical Center Heart
Center. These patients were contacted regarding their interest in participating in an
optional research study. They were met after appointments with their cardiac health
providers, and administered a testing battery identical to that used with the CR patients.
Additionally, control patients were consented using documentation approved through the
Loma Linda University IRB board (Appendix 1). Each patient was given a copy of the
research agreement, with a signed copy kept by the investigators.

Analyses
To test the aims and hypotheses, hierarchical linear and logistic regression models
were employed, as discussed above. These models were tested using SPSS 17, and
included appropriate assumptions testing for each analysis. Because no pilot data exist,
an a priori power analysis was not possible.

Pre-Analysis Data Cleaning and Assumption Checking
Pre-analysis statistical procedures and assumption checking were completed to
clean the data and ensure adherence to regression-specific assumptions (Tables 1, 2, & 3).
The effects of gender were first examined by correlating gender with dependent
variables. No significant correlations were observed, thus gender was not included in the
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final model. This finding supports normative data used in interpretation of the RBANS
and other employed measures, which do not find it necessary to control for gender
(Bechtoldt, et al., 1962; Delis, et al., 2001; Randolph, 1998; Randolph, et al., 1998; Ruff,
et al., 1996; Wechsler, 2001, 2008).
Data cleaning focused on removing subjects with missing data or those with
primarily non-cardiac diagnoses. At the start of this procedure, there were a total of 73
subjects in the analysis (60 rehabilitation subjects and 13 controls). Subjects were
included only if they possessed a primary cardiac diagnosis and had fully complete data
(listwise deletion). The final sample size was 52 subjects (41 rehabilitation and 11
controls).
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Table 1
Descriptive Data for Aim 1.
95% CI
Mean

SD

Lower

Upper

Min

Max

Heart Failure

0.32

0.47

0.17

0.47

0

1

Hypertension

0.63

0.49

0.48

0.79

0

1

Surgeries

2.88

1.68

2.35

3.41

0

7

Education

4.24

1.77

3.68

4.80

1

7

104.85

12.58

100.88

108.82

72

125

Depression

1.10

1.20

0.72

1.48

0

4

Anxiety

1.22

1.19

0.84

1.60

0

4

Stress

5.12

3.60

3.99

6.26

0

15

RBANS Attention Index

94.39

19.88

88.12

100.67

53

138

RBANS Immed. Mem. Index

87.88

17.46

82.37

93.39

41

117

RBANS Del. Mem. Index

92.68

16.67

87.42

97.94

43

124

Digit Span Bck (Wk. Mem.)

9.29

3.04

8.33

10.25

4

17

Executive Composite Index

-0.22

1.05

-0.55

0.11

-2.75

2.61

D-KEFS Trails 5 (Psy. Sp.)

10.71

2.32

9.98

11.44

4

14

RBANS VisuoSpatial Index

87.71

16.11

82.62

92.80

36

116

Premorbid IQ
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Table 2
Descriptive Data for Aim 2.
Control

Rehabilitation
95% CI

95% CI

Mean

SD

Lower

Upper

Mean

SD

Lower

Upper

4.55

1.51

3.53

5.56

4.24

1.77

3.68

4.80

Premorbid IQ

107.45

9.61

101.00 113.91 104.85

12.58

100.88 108.82

RBANS Attn.

102.00

20.05

88.53

115.47

94.39

19.88

88.12

100.67

RBANS IM

95.27

14.02

85.85

104.69

87.88

17.46

82.37

93.39

RBANS DM

98.18

13.29

89.26

107.11

92.68

16.67

87.42

97.94

DS Bck

9.64

4.03

6.93

12.34

9.29

3.04

8.33

10.25

Exec Fnct.

0.01

0.81

-0.54

0.55

-0.22

1.05

-0.55

0.11

Trails

12.18

1.17

11.40

12.97

10.71

2.32

9.98

11.44

Education
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Table 3
Zero-order correlations.
1

2

3

4

5

6

7

8

9
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Heart Failure

1.00

Hypertension

-.14

1.00

Surgeries

.43**

.07

1.00

Education

.06

.25

.09

1.00

Premorbid IQ

.07

.20

.29

.71**

1.00

Depression

.08

.15

-.03

-.06

-.11

1.00

Anxiety

.18

.10

-.19

-.10

-.19

.84**

1.00

Stress

.17

.21

.02

-.14

-.15

.77**

.74**

1.00

RBANS Attn.

-.18

.29

.18

.36*

.40**

-.13

-.08

-.05

1.00

RBANS IM

.18

.38*

.27

.30

.41**

-.10

.01

.01

.51**

10

1.00

11

12

13

14

15

RBANS DM

.16

.41**

.14

.26

.24

.04

.14

.07

.40**

.68**

1.00

DS Bck

-.17

.31*

.16

.44**

.45**

-.02

-.07

-.07

.55**

.49**

.29

1.00

Exec Fnct.

-.09

.31*

.27

.47**

.64**

-.06

-.14

-.05

.62**

.54**

.50**

.52**

1.00

Trails

-.21

.04

.09

.22

.33*

-.23

-.15

-.12

.51**

.31*

.20

.19

.49**

1.00

RBANS VS

.28

.06

.31*

.29

.33*

-.11

-.06

-.02

.41**

.45**

.63**

.17

.37*

.24

*p < .05 **p < .01

1.00
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Aim 1
Assumption checking was completed for the hierarchical linear regression models
for Aim 1. The form of relationship (linearity) assumption was tested by examining
scatterplots of independent variables on each dependent variable. Loess fit lines were
computed for each relationship. The relationship between each predictor and its
dependent variable were generally linear in appearance, and thus no significant deviations
from this assumption were noted.
The correct specification of independent variables assumption was tested by
conceptually examining the inclusion of each variable. Since all variables in this study
were chosen based on background research, no variables were excluded. Based on theory
and previous research, each variable should contribute to the regression models.
The assumption of no measurement error was examined conceptually and through
reliability analyses. Although formal reliability data were not reported in the literature,
measures were chosen for this study based on their applicability to the chosen patient
population. Formal reliability analyses were also computed using Cronbach’s α for both
multi-item predictors and functional domains, as well as the seven regression models.
Reliability data for predictors and functional domains were generally acceptable (Table
4). Values of α for most of the seven regression models (nine variables in total for each
model) demonstrated poor reliability, which likely resulted in attenuated relationships
with the variables of interest. These values are somewhat lower than the value of .7
generally needed for conducting group research (Furr & Bacharach, 2007). No action
was taken due to each variable being specifically selected for this study based on
conceptual backing in the literature.
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Table 4
Reliability Data for Regression Models and Independent Predictors.
Reliability (Cronbach’s α)
Predictors Only

.21

Attention Model

.36

Immediate Memory Model

.39

Delayed Memory Model

.33

Working Memory Model

.33

Executive Functioning Model

.28

Psychomotor Speed Model

.27

Visuospatial Model

.36

PHQ-9

.90

GAD-7

.91

PSS-4

.10

RBANS Attention Index

.42

RBANS Immediate Memory Index

.64

RBANS Delayed Memory Index

.63

Executive Composite

.69

RBANS Visuospatial Index

.14
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The assumption of homoscedasticity was tested by examining the spread of
standardized residuals from each model across independent variables values. The
assumption seemed to generally be met. Although some variables, such as depression
and stress, displayed mild cases of heteroscedasticity for the immediate memory model,
the overall trend for all variables was towards homoscedasticity.
The assumption of normal distribution of residuals was examined using a series of
Q-Q plots. While some models, such as working memory and psychomotor speed, had
several residuals that were not quite as normally distributed as other models, no
significant violations occurred.
Multivariate outliers were assessed by examining measures of influence, which
take into account both leverage and discrepancy data. DFFITS and Cook’s D metrics
were obtained for all Aim 1 analyses, and visualized using index plots. Several cases
exhibited marginally high amounts of influence on one or two analyses, but none
exhibited undue leverage to the degree that warranted removing them from the analyses.
Multicollinearity was assessed by examining tolerance and VIF statistics for all
analyses. No multicollinearity, defined as Tolerance < .10 or VIF > 10, was detected.
The lowest level of tolerance observed was .21 for anxiety in the model analyzing
visuospatial functioning; this variable also exhibited the highest VIF, a value of 4.9, in
the same analysis.

Aim 2
Assumption checking was also completed on the logistic regression for Aim 2.
Expected frequencies were not computed due to the lack of categorical independent
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variables.
Linearity in the logit was computed using the Box-Tidwell approach (Tabachnick
& Fidell, 2006). No interaction terms were significant, suggesting appropriate linearity
between continuous independent variables and the logit of the dependent variable.
Multicollinearity was assessed for continuous predictors by examining the
standard errors of predictors (Tabachnick & Fidell, 2006). Multicollinearity was further
assessed by examining tolerance and VIF statistics, using the same cutoffs as described
above. No multicollinearity was found.
Outliers were examined using standardized residuals. While overall residual
values were quite low (M = 0.02, SD = 0.93), control patients tended to have larger
residual values than rehabilitation patients; the highest residual value was -3.04. No
control patients were eliminated from the analysis, however, given the small final sample
size (n = 11).
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CHAPTER FIVE
RESULTS

Aim 1
Attention
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better attention was partially confirmed
(Table 5). The first step of the hierarchical regression analysis, which included CHF
status, hypertension status, and surgery history, did not account for a significant
proportion of the variance in attention, F(3, 37) = 2.47, p > .07. The regression model at
step 1 accounted for 17% of the variance in attention. None of the included variables
were significant individual predictors.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ accounted for a significant proportion
of the variance in attention above and beyond all previously entered predictor variables,
ΔF(2, 35) = 2.69, ΔR² = .11. The total regression model at step 2 accounted for 28% of
the variance in attention. No single variables were significant predictors in this model.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = 1.42, ΔR² = .09. The final regression model at step 3 accounted
for 36% of the variance in attention. Of the individual variables, heart failure served as a
significant individual predictor of attention, t(39)= -2.29, p < .03. The unstandardized
regression coefficient for this variable was -17.16, suggesting that, while controlling for
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other independent variables in the model, patients with CHF scored 17.16 points less on
the attention index than patients without CHF. Depression served as a marginally
significant predictor, t(39) = -2.00, p < .053. The unstandardized regression coefficient
for this variable was -9.98, suggesting that, while controlling for other independent
variables in the model, as depression increased by one point, attention decreased by 9.98
points.
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Table 5
Attention as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

-11.35

7.13

-.27

Hyp.

9.51

6.24

Surg.

3.35

1.99

Model 3
β

B

-11.57

6.88

-.27

-17.16

7.51

-.41*

.10

.23

6.22

6.17

.15

5.30

6.37

.13

.01

.28

2.56

2.02

.22

4.11

2.20

.35

.07

Edu.

1.99

2.38

.18

2.32

2.36

.21

.02

Pr. IQ

0.32

0.34

.20

0.33

0.34

.21

.02

Dep.

-9.98

4.98

-.60

.08

Anx.

8.82

5.18

.53

.06

Stress

0.64

1.34

.12

.00

HF

SE B

R2

.17

.28

.36

F

2.47

2.69*

2.28*

∆F

2.47

2.69

1.42

β

sr2

SE B

*p < .05 **p < .01

Immediate Memory
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better immediate memory was confirmed
(Table 6). The first step, which included CHF status, hypertension status, and surgery
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history, accounted for a significant proportion of the variance in immediate memory, F(3,
37) = 3.51, p < .03. The regression model at step 1 accounted for 22% of the total
variance in immediate memory. Of the individual variables, only hypertension was a
significant predictor, t(39) = -2.62, p < .02. The unstandardized regression coefficient for
this variable was 13.89, suggesting that, while controlling for the other independent
variables in the model, individuals with hypertension scored 13.89 points higher on the
immediate memory index than those without.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ did not account for a significant
proportion of the variance in immediate memory above and beyond all previously entered
predictor variables, ΔF(2, 35) = 2.12, ΔR² = .08. The total regression model at step 2
accounted for 31% of the variance in immediate memory. Hypertension remained a
significant predictor of attention, t(39)= -2.30, p < .03. Individuals with hypertension
scored 12.19 points higher on the immediate memory index than individuals without
hypertension.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in immediate memory above and beyond all previously entered
predictor variables, ΔF(3, 32) = 1.44, ΔR² = .08. The final regression model at step 3
accounted for 39% of the total variance in immediate memory. Hypertension remained a
significant predictor of attention, t(39)= -2.26, p < .04. Individuals with hypertension
scored 12.38 points higher on the immediate memory index than those without
hypertension.
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Table 6
Immediate Memory as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

5.60

6.10

.15

Hyp.

13.89

5.29

Surg.

1.85

1.69

Model 3
β

1.97

6.46

.05

.00

.34*

12.38

5.48

.35*

.10

1.74

.08

2.22

1.89

.21

.03

-0.48

2.05

-.05

-0.38

2.03

-.04

.00

0.48

0.30

.34

0.48

0.29

.34

.05

Dep.

-8.18

4.29

-.56

.07

Anx.

8.06

4.46

.55

.06

Stress

-0.07

1.15

-.06

.00

Edu.
Pr. IQ

β

B

6.16

5.93

.17

.39*

12.19

5.31

.18

0.84

sr2

SE B

HF

SE B

R2

.22

.31

.39

F

3.51*

3.08*

2.54*

∆F

3.51*

2.12

1.44

*p < .05 **p < .01

Delayed Memory
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better delayed memory was partially

71

confirmed (Table 7). The first step, which included CHF status, hypertension status, and
surgery history, accounted for a significant proportion of the variance in delayed
memory, F(3, 37) = 3.36, p < .03. The regression model at step 1 accounted for 21% of
the total variance in delayed memory. Of the individual variables, only hypertension was
a significant predictor, t(39) = -2.94, p < .01. The unstandardized regression coefficient
for this variable was 14.93, suggesting that, while controlling for the other independent
variables in the model, individuals with hypertension scored 14.93 points higher on the
delayed memory index than those without.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ did not account for a significant
proportion of the variance in delayed memory above and beyond all previously entered
predictor variables, ΔF(2, 35) = 0.55, ΔR² = .02. The total regression model at step 2
accounted for 24% of the variance in delayed memory. Hypertension remained a
significant predictor of attention, t(39) = -2.56, p < .02. Individuals with hypertension
scored 13.62 points higher on the delayed memory index than those without.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = 0.06, ΔR² = .06. The final regression model at step 3 accounted
for 29% of the total variance in delayed memory. Hypertension remained a significant
predictor of attention, t(39) = -2.46, p < .02. Individuals with hypertension scored 13.80
points higher on the delayed memory index than those without.
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Table 7
Delayed Memory as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

7.37

5.81

.21

Hyp.

14.93

5.08

Surg.

0.17

1.62

Model 3

SE B

β

B

7.24

5.93

.21

.44*

13.62

5.31

.40*

.02

-0.11

1.74

Edu.

0.88

Pr. IQ

0.11

sr2

SE B

β

3.65

6.63

.10

.01

13.80

5.62

.40*

.14

-.01

1.17

1.94

.12

.01

2.05

.09

0.82

2.09

.09

.00

0.30

.08

0.13

0.30

.09

.00

Dep.

-4.70

4.40

-.34

.03

Anx.

7.23

4.57

.52

.06

Stress

-0.64

1.18

-.14

.01

HF

R2

.21

.24

.29

F

3.36*

2.18

1.66

∆F

3.36*

0.55

0.85

*p < .05 **p < .01

Working Memory
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better working memory was partially
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confirmed (Table 8). The first step, which included CHF status, hypertension status, and
surgery history, did not account for a significant proportion of the variance in working
memory, F(3, 37) = 2.38, p > .08. The regression model at step 1 accounted for 16% of
the total variance in working memory. None of the included variables served as
significant individual predictors in this model.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ accounted for a significant proportion
of the variance in working memory above and beyond all previously entered predictor
variables, ΔF(2, 35) = 4.24, ΔR² = .16. The total regression model at step 2 accounted
for 33% of the variance in working memory. No included variables served as individual
predictors.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = 0.16, ΔR² = .01. The final regression model at step 3 accounted
for 34% of the total variance in working memory. There were no significant individual
predictors.
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Table 8
Working Memory as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

-1.56

1.09

-.24

Hyp.

1.63

0.96

Surg.

0.45

0.31

Model 3

SE B

β

B

-1.63

1.02

-.25

.26

1.00

0.91

.25

0.32

Edu.
Pr. IQ

sr2

SE B

β

-1.91

1.17

-.30

.06

.16

0.99

0.99

.16

.02

0.30

.18

0.42

0.34

.23

.03

0.43

0.35

.25

0.53

0.37

.25

.03

0.05

0.05

.21

0.05

0.05

.21

.02

Dep.

-0.23

0.78

-.09

.00

Anx.

0.53

0.81

.21

.01

Stress

-0.06

0.21

-.07

.00

HF

R2

.16

.33

.34

F

2.38

3.38*

2.02

∆F

2.38

4.24*

0.16

*p < .05 **p < .01

Executive Functioning
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better executive functioning was confirmed
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(Table 9). The first step, which included CHF status, hypertension status, and surgery
history, accounted for a significant proportion of the variance in executive functioning,
F(3, 37) = 2.90, p < .05. The regression model at step 1 accounted for 19% of the total
variance in executive functioning. Of the included variables, surgery history served as an
individual predictor. After controlling for other variables in the model, there was a 0.21point increase in executive functioning for each additional surgery a patient had
undergone
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ accounted for a significant proportion
of the variance in executive functioning above and beyond all previously entered
predictor variables, ΔF(2, 35) = 9.54, ΔR² = .29. The total regression model at step 2
accounted for 48% of the variance in executive functioning. Of the individual variables,
only premorbid IQ served as a significant predictor, t(39) = 2.87, p < .01. After
controlling for other variables in the model, every one-point increase in premorbid IQ
was accompanied by a .04 point increase in executive functioning.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = 0.06, ΔR² = .01. The final regression model at step 3 accounted
for 48% of the total variance in executive functioning. Premorbid IQ remained a
significant predictor of executive functioning, t(39) = 2.75, p < .01. After controlling for
other variables in the model, every one-point increase in premorbid IQ was accompanied
by a .04-point increase in executive functioning.

76

Table 9
Executive Functioning as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

-0.44

0.37

-.20

Hyp.

0.56

0.32

Surg.

0.21

0.10

Model 3

SE B

β

B

-0.41

.037

-.18

.26

0.33

0.28

.34*

0.12

Edu.
Pr. IQ

sr2

SE B

β

-0.45

0.36

-.20

.03

.15

0.30

0.30

.14

.02

0.09

.18

0.12

0.10

.19

.02

0.03

0.11

.05

0.03

0.11

.06

.00

0.04

0.12

.53**

0.04

0.02

.53**

.12

Dep.

-0.07

0.24

-.08

.00

Anx.

0.02

0.25

.03

.00

Stress

0.02

0.06

.08

.00

HF

R2

.19

.48

.48

F

2.90*

6.36**

3.68**

∆F

2.90*

9.54**

0.06

*p < .05 **p < .01

Psychomotor Speed
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are associated with better psychomotor speed was not
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confirmed (Table 10). The first step, which included CHF status, hypertension status,
and surgery history, did not account for a significant proportion of the variance in
psychomotor speed, F(3, 37) = 1.17, p < .34. The regression model at step 1 accounted
for 9% of the total variance in psychomotor speed. No included variables served as
significant individual predictors.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ did not account for a significant
proportion of the variance in psychomotor speed above and beyond all previously entered
predictor variables, ΔF(2, 35) = 2.04, ΔR² = .10. The total regression model at step 2
accounted for 18% of the variance in psychomotor speed. No included variables served
as significant individual predictors.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = .1.73, ΔR² = .11. The final regression model at step 3 accounted
for 30% of the total variance in psychomotor speed. Of the included variables, both heart
failure status, t(39) = -2.31, p < .03, and depression, t(39) = -2.28, p < .03, served as
individual predictors. After controlling for other variables in the model, individuals with
heart failure scored 2.13 points less on the measure of psychomotor speed than those
without. Depressed patients experienced a 1.39 drop in psychomotor speed for every
one-point increase in their depressive symptoms, after controlling for other variables.
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Table 10
Psychomotor Speed as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

Model 3

SE B

β

B

SE B

β

sr2

HF

-1.54

0.87

-.31

-1.49

0.85

-.30

-2.13

0.92

-.43*

.12

Hyp.

-0.10

0.76

-.02

-0.39

0.77

-.08

-0.49

0.78

-.10

.01

Surg.

0.32

0.24

.23

0.19

0.25

.14

0.36

0.27

.26

.04

Edu.

0.03

0.29

.02

0.08

0.29

.06

.00

Pr. IQ

0.06

0.04

.31

0.06

0.04

.31

.04

Dep.

-1.39

0.61

-.72*

.12

Anx.

0.99

0.63

.51

.05

Stress

0.13

0.16

.20

.01

R2

.09

.18

.30

F

1.17

1.56

1.68

∆F

1.17

2.04

1.73

*p < .05 **p < .01

Visuospatial Functioning
The hypothesis that having fewer medical problems, higher cognitive reserve, and
fewer affective symptoms are not associated with better visuospatial functioning (null
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hypothesis) was confirmed (Table 11). The first step, which included CHF status,
hypertension status, and surgery history, did not account for a significant proportion of
the variance in visuospatial functioning, F(3, 37) = 1.80, p < .17. The regression model
at step 1 accounted for 13% of the total variance in visuospatial functioning. No included
variables served as significant individual predictors.
The second step of the model added in education and premorbid IQ. The optimal
linear combination of education and premorbid IQ did not account for a significant
proportion of the variance in visuospatial functioning above and beyond all previously
entered predictor variables, ΔF(2, 35) = 1.62, ΔR² = .07. The total regression model at
step 2 accounted for 20% of the variance in visuospatial functioning. No included
variables served as significant individual predictors.
The third step of the model added depression, anxiety, and stress. The optimal
linear combination of depression, anxiety, and stress did not account for a significant
proportion of the variance in attention above and beyond all previously entered predictor
variables, ΔF(3, 32) = 0.43, ΔR² = .03. The final regression model at step 3 accounted
for 23% of the total variance in visuospatial functioning. No included variables served as
significant individual predictors.
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Table 11
Visuospatial Functioning as a Function of Health, Cognitive, and Affective Predictors.
Model 1
B

Model 2

SE B

β

B

Model 3

SE B

β

B

SE B

β

sr2

HF

6.76

5.92

.20

6.58

5.87

.19

4.58

6.68

.13

.01

Hyp.

2.25

5.18

.07

0.05

5.26

.00

-0.23

5.66

-.01

.00

Surg.

2.11

1.65

.22

1.60

1.72

.17

2.11

1.95

..22

.03

Edu.

1.39

2.02

.15

1.58

2.10

.17

.01

Pr. IQ

0.20

0.29

.16

0.19

0.30

.15

.01

Dep.

-5.01

4.43

-.37

.03

Anx.

3.08

4.61

.23

.01

Stress

0.54

1.19

.12

.00

R2

.13

.20

.23

F

1.80

1.77

1.21

∆F

1.80

1.62

0.43

*p < .05 **p < .01

Aim 2
The hypothesis that having higher cognitive reserve and better cognitive
functioning are associated with a greater likelihood to attend cardiac rehabilitation was
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not confirmed (Table 12). The Hosmer-Lemeshow goodness of fit statistic for the first
step, which included education and premorbid IQ, was not significant, χ²(8) = 5.85, p <
.7, suggesting good discrimination and fit of the model for the data. However, no
individual predictor significantly predicted cardiac rehabilitation status.
The second step of the model added in attention, immediate memory, delayed
memory, working memory, executive functioning, and psychomotor speed. The HosmerLemeshow goodness of fit statistic was not significant, χ²(8) = 8.06, p < .5, suggesting
good discrimination and fit of the model. As in step one, no individual predictor
significantly predicted cardiac rehabilitation status.
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Table 12
Cognitive Rehabilitation Enrollment as a Function of Cognitive Reserve and
Neuropsychological Predictors.
Model 1
B

Model 2

Wald
χ²

OR

95%
CI

B

Wald
χ²

OR

95%
CI

Education

-.10

0.12

0.91

0.53,
1.57

-.23

0.55

0.79

0.43,
1.46

Premorbid IQ

-.01

0.12

0.99

0.91,
1.07

.03

0.21

1.03

0.92,
1.14

RBANS Attn.

.00

0.00

1.00

0.95,
1.05

RBANS IM

-.03

0.62

0.97

0.89,
1.05

RBANS DM

-.01

0.04

0.99

0.93,
1.06

DS Bck

.07

0.23

1.07

0.80,
1.44

Exec Fnct.

.23

0.18

1.26

0.43,
3.68

Trails

-.43

2.58

0.65

0.38,
1.10

R2

.01

.10

χ²

0.83

6.42

∆ χ²

0.83

5.59

*p < .05 **p < .01
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CHAPTER SIX
DISCUSSION

The overall results from this experiment show that health, cognitive reserve, and
affective variables do predict cognitive functioning in heart patients across several
functional domains (Table 13). One or several of these variables were effective in
predicting attention, immediate memory, delayed memory, executive functioning, and
psychomotor speed. Cognitive ability predictors did not successfully predict
participation in cardiac rehabilitation programs.

Table 13
Table of Significant Individual Predictors for Aim 1.
Attn.
Heart Failure

Imm.
Mem.

Del.
Mem.

Wor.
Mem.

Ex.
Func.

√

Hypertension

Psy.
Speed
√

√

√

Surgeries

√

Education
Premorbid IQ
Depression

√
~√

√

Anxiety
Stress
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VisSpa.

Aim 1 Conclusions
Health, cognitive reserve, and affective variables partially predicted attention in a
mixed diagnosis sample of heart patients. While health variables were marginally
predictive of attention, the addition of both variables related to cognitive reserve and
affective variables greatly improved the model, leading from an initial R² of .17 to a final
value of .36. While the initial model was marginally significant (p > .07), it is likely that
the model would be statistically significant with a larger sample size. In the final model,
only heart failure served as a significant individual predictor of attention. Specifically,
patients with CHF demonstrated significantly worse attention. This finding is congruent
with previous research, which suggests that patients with CHF experience the largest
impact on cognitive functioning (Beer, et al., 2009; Bennett & Sauve, 2003; Rengo, et al.,
1995; Vogels, Oosterman, et al., 2007). Additionally, depression served as a marginally
significant predictor of attention. While there is some contention over depression’s
effects on overall cognition in heart patients, no studies have examined the specific
relationship between depression and attention in this population, although it is associated
with decreased attention in the general population (Baune, et al., 2010; Beer, et al., 2009;
Bennett & Sauve, 2003; Bennett, et al., 2005; Delgado & Schillerstrom, 2009; Vogels,
Oosterman, et al., 2007). Given the marginally significant finding in this study, as well
as the moderate effect size (sr2 = .28), it is possible that depression may have some
influence on attention in heart patients. Since attention mediates other cognitive
domains, like memory, any impact on attention can have wider functional consequences
(Mitrushina, et al., 2005; Strauss, et al., 2006). It is likely that the effect of this variable
would have been statistically significant with a larger sample size.
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Predictor variables successfully delineated immediate memory. While the final
model was significant, the initial step containing health variables, particularly
hypertension, accounted for the most variance in immediate memory, as evidenced by the
largest sr² values. Hypertension exhibited a significant positive relationship with
immediate memory, suggesting better memory among those diagnosed with
hypertension. There are several plausible explanations for this relationship. First,
although hypertension is known to adversely affect memory in the general population
(Cherubini, et al., 2007; Feinberg & Farah, 2003; van Swieten, et al., 1991), it generally
affects cognition in heart patients indirectly as a precursor to the development of CAD or
CHF (Bennett & Sauve, 2003; Bennett, et al., 2005; Vogels, Oosterman, et al., 2007;
Wynands, et al., 1970). Thus, the relationship between hypertension and memory is
potentially not direct, and may be mediated by heart-related factors, which could explain
its seemingly beneficial relationship with memory. The more likely explanation relates
to treatment. While hypertension is a risk factor for cognitive dysfunction, this
relationship is contingent on the long-term poor management of blood pressure
(Cherubini, et al., 2007). Because of the fact that the sample for this study contained
patients undergoing medical treatment for heart problems, it is likely that all individuals
with a diagnosis of hypertension were also being treated for their symptoms. Such
treatment may explain why an opposite relationship between hypertension and memory
was observed; isolating those treated only for hypertension could help clarify this
discrepancy. Multicollinearity effects were not observed for this model, and thus are
likely not responsible for the aberrant finding regarding hypertension and immediate
memory.
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Predictor variables were moderately successful in predicting delayed memory.
The first step of the model, consisting only of medical variables, successfully predicted
delayed memory functioning. This relationship was again contingent on a positive
relationship between hypertension and memory, likely due to either mediation by heartrelated factors or the fact that all persons diagnosed with hypertension in a medical
setting likely had their symptoms controlled through treatment paradigms. However,
neither the cognitive reserve nor affective variables contributed overall to the model,
likely due to decreasing power with the addition of more predictors. While anxiety
explained a moderate amount of unique variance in delayed memory (sr2 = .24), this
individual relationship was not significant, possibly due to poor reliability or low power.
Predictor variables were moderately successful in predicting working memory.
While medical variables, particularly hypertension, were associated with the working
memory, they did not add enough unique variance as a group for a significant first step.
The second step, however, was associated with a significant increase in R2, leading to
overall significance for the model. Semi-partial correlations revealed that education and
premorbid IQ exhibited roughly equal contributions to the final model (.03 and .02,
respectively). The addition of the third step rendered the final model non-significant,
likely due to reduced power subsequent to the additional predictors.
Predictor variables successfully predicted executive functioning. Medical
variables added significantly to the model, driven primarily by surgery history. Similar
to hypertension in previous models, surgery history was positively associated with
executive functioning, rather than being negatively associated as expected. Statistically,
this relationship could be due to the relationship between number of surgeries and
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hypertension. These two variables were significantly related according to their zeroorder correlations; given the fact that they both have exhibited counterintuitive
relationships with dependent variables in this study, the observed effects could be due to
multicollinearity. However, further analysis revealed that tolerance and VIF statistics for
this model did not suggest the presence of multicollinearity. Methodological
explanations include the possibility that patients with more numerous surgeries have had
their cardiac problems mostly corrected, thus explaining the positive relationship. A
more plausible explanation, however, involves the timeline of POCD after major surgery.
While up to 25% of patients can exhibit deficits up to 6 months out, POCD is known to
eventually resolve for the vast majority of patients, given enough time (Newman, et al.,
2001; Ropacki, et al., 2007; Royter, et al., 2005; Selnes, et al., 1999; Sun, et al., 2012;
van Dijk, et al., 2000). The surgery history variable for this study examined the total
number of surgeries, not contingent on time. Thus, any POCD symptoms may have
resolved by the time of the neuropsychological evaluation. The second step of the model
explained a significant amount of additional variance in executive functioning, primarily
due to the effects of premorbid IQ. Affective variables added very little to the final
model, as evidenced by their small semipartial correlations.
Predictor variables were somewhat successful in predicting psychomotor speed.
While heart failure status was marginally significantly associated with psychomotor
speed, this relationship was not strong enough for the first step of the model to be
significant. Additionally, while both education and premorbid IQ were marginally
associated with psychomotor speed, neither predictor contributed significantly to the
model. Depression and heart failure were significantly associated with psychomotor
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speed in the final model; however this relationship was not statistically powerful enough
to render the step or overall model significant. Because of the final R² of .30, it is likely
that this final step would have been significant given a larger sample size. While
depression generally leads to psychomotor slowing (Baune, et al., 2010; Delgado &
Schillerstrom, 2009), it is possible that this effect is somehow mediated or attenuated in
heart patients. Interestingly, although psychomotor speed is often impaired in heart
patients (Hoth, et al., 2008; Tiemann, Penner, et al., 2009; Vogels, Scheltens, et al.,
2007), the mean for patients in the present study was close to the 50th percentile,
suggesting this sample of heart patients did not experience a decline in this area. Thus,
the relative sparing of psychomotor abilities in the present study, illustrated by the fact
that patients scored no different from the normal range for healthy participants, may help
to explain possible mediation between depression and psychomotor speed. Although it is
unknown why psychomotor speed was spared in this sample, it could be due to the
normative data used to score the D-KEFS Trails paradigm. The inclusion of other
psychomotor tests, such as the grooved pegboard or finger tapping test, could provide
some perspective on this finding.
As hypothesized, predictor variables were not successful in predicting
visuospatial functioning. While it is possible that health variables would have led to a
significant initial step given a larger sample size, the present study found no association.
While some evidence exists of visuospatial memory deficits in the heart population,
visuospatial ability as a whole is generally unaffected (Bauer & Pozehl, 2010; Bennett &
Sauve, 2003; Bennett, et al., 2005; Sauve, et al., 2009).
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It should be noted that many analyses in Aim 1 would benefit from additional
participants, ideally approaching the suggested 10 subjects per predictor (Tabachnick &
Fidell, 2006). As mentioned in the results and discussion sections, there were several
instances where one step of a model would be significant, only to be rendered nonsignificant by the addition of additional predictors at a later step. Because of the fact that
once any model reaches overall significance it should retain it, this phenomenon is best
understood to result from low statistical power due to a restricted sample size. Thus,
although Aim 1 overall exhibited good confirmation of hypotheses, the results would
likely be strengthened with the inclusion of additional subjects.

Aim 2 Conclusions
Predictor variables were not successful in predicting participation in cardiac
rehabilitation based on cognitive factors. There are several reasons that may explain this
finding. Statistically, the low number of control subjects (n = 11), relative to
rehabilitation subjects (n = 41) may have resulted in low statistical power or
heterogeneity of variance. Based on the suggested sample size of 10 subjects per
predictor (Tabachnick & Fidell, 2006), the final sample size of 52 subjects was below the
70-80 suggested. To examine the effects that a low N may have had, exploratory
analyses were conducted by collapsing all cognitive variables into a single predictor by
converting each variable to a z-score and combining into a composite measure. This
model, like the full-scale model, was not statistically significant, suggesting that the
failure of the full model to predict admittance to rehabilitation may be a true finding.
Final Cox and Snell R² for the full model was .036, suggesting that only 3.6% of the
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decision on whether to attend rehabilitation or not was contingent on cognitive factors.
Of the individual predictors, processing speed was the closest to significance.
The lack of cognitive explanations for the decision to attend rehabilitation
suggests other factors are at work. Possible explanations include that not all heart
patients were actually offered or referred to rehabilitation as was assumed. If this were
the case, it could introduce random error into the analysis. It is also possible that other
factors such as limited availability, satisfaction with current treatment options, or other
factors affected this analysis. That is, patients who are currently being treated in the heart
clinic may have rejected participation in cardiac rehabilitation not because of a cognitive
factor, but due to the fact that they were satisfied with their current treatment options or
lacked the time to commit to attending rehabilitation several times per week. Finally, it is
possible that the final model lacked the necessary sample size, resulting in a Type II
error. Data will continue to be collected prior to publication, ensuring a sufficient sample
size to reduce the likelihood of such an error.

Summary
In summary, several health and cognitive factors affect neuropsychological
functioning in heart patients across many of the domains identified. Health-related
factors appear to have an impact on cognitive functioning in this population. This set of
variables significantly predicted immediate memory, delayed memory and executive
functioning, suggesting that the combination of hypertension, heart failure status, and
surgery history influences cognitive functioning on its own, without the addition of other
factors. Both heart failure status and hypertension served as individual predictors in
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several models although, paradoxically, hypertension was often positively associated
with cognitive functioning. This relationship, as discussed above, may be due to the fact
that patients with a diagnosis of hypertension in a medical setting are likely being treated
for their symptoms.
Cognitive reserve-related factors also had predictive power in heart patients, after
controlling for health-related factors. The effects of variables associated with cognitive
reserve were particularly notable in the domains of attention, working memory, and
executive functioning, where they worked in concert to predict performance.
Individually, the only significant predictor was premorbid IQ in the model predicting
executive functioning. The lack of individual predictive power observed with the
education variable is likely methodological; although multicollinearity was not observed,
WTAR scores correct for education, and thus may restrict any individual influence that
education may provide. Based on the small but relevant effect sizes uniquely attributable
to premorbid IQ for a variety of non-significant domains, including immediate memory
(sr2 = .05) and psychomotor speed (sr2= .04), it is likely that additional significant
relationships would have appeared given better model reliability or additional power
(Ferguson, 2009).
Affective predictors did not predict cognitive functioning as well as initially
hypothesized. Of the regression models, the only marginally significant finding was a
tenuous association between depression and both attention and psychomotor speed.
While the effects of depression, anxiety, and stress are clearly linked with cognitive
difficulties, including reduced attention (Alagiakrishnan, et al., 2006; Baune, et al., 2010;
Cherubini, et al., 2007; Delgado & Schillerstrom, 2009; Freedland, et al., 2009; Kent &
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Shapiro, 2009; Vogels, Oosterman, et al., 2007; Vogels, Scheltens, et al., 2007), their
relationships with cognitive functioning in heart patients is less clear (Bennett & Sauve,
2003; Grubb, et al., 2000; Pressler, 2008; Sauve, et al., 2009). While these affective
variables were significantly associated with many dependent variables on zero-order
correlations, they conferred little additional variance after controlling for health and
cognitive-related factors. Given the medium observed effect sizes uniquely attributable
to affective variables for domains including attention, immediate memory, and
psychomotor speed, it is likely that the lack of significance for these variables is due to
either poor reliability or low power.

Implications
Cognitive dysfunction in cardiac patients is well documented, and may affect
treatment adherence (Bauer, et al., 2011; Bennett & Sauve, 2003; Bennett, et al., 2005;
Sauve, et al., 2009; Vogels, Oosterman, et al., 2007; Vogels, Scheltens, et al., 2007).
Findings from the present study suggest that patients with health comorbidities common
in heart patients likely experience more cognitive dysfunction, which could affect
treatment. As a result, properly managing hypertension and CHF, as well as limiting the
number of surgeries, could lead to better cognitive outcomes, improving treatment
adherence. For patients with any of the abovementioned conditions, efforts to encourage
treatment adherence such as psychoeducation; utilization of pill boxes, notebooks, and
other compensatory strategies to track medications; as well as follow-up care to ensure
treatment adherence may lead to decreased morbidity and better health outcomes.

93

Cognitive reserve findings suggest that, similar to the Alzheimer’s Dementia
literature (Ropacki, et al., 2007; Stern, 2002, 2009; Vemuri, et al., 2011), cardiac patients
with better reserve-related abilities likely experience better neuropsychological abilities
than those who scored lower on reserve-related measures, even after controlling for
health-related factors. Thus, cardiac patients with higher levels of reserve-related factors,
including premorbid IQ, have better executive functioning, which may additionally lead
to better health outcomes and reduced morbidity. To help correct for this factor, cardiac
patients with low education or premorbid IQ could be engaged in additional methods to
encourage treatment adherence, similar to those described above to correct for healthrelated factors.
Affective findings suggest that addressing health and cognitive factors, rather than
affective difficulties, may be most helpful to heart patients, given the former’s stronger
relationship with cognitive ability. However, given the high levels of subjective distress,
morbidity, and even mortality associated with affective factors, adding or continuing
treatment for these conditions, especially depression, may lead to better health outcomes
(Bennett & Sauve, 2003; Carney & Freedland, 2009; Cherubini, et al., 2007; Kent &
Shapiro, 2009; Moser, et al., 1999; Naqvi, et al., 2005). Thus, while treating depression
and other affective factors may have limited effects on cognitive ability in heart patients,
the literature supports the positive effects that treatment of these conditions has for
overall health.

Future Directions
Findings from this study suggest several future directions. Primarily, given the
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low sample size for control patients, revisiting Aim 2 after more subjects are recruited
could alter the findings observed in the present study. This aim will only be considered
for publication if and when the recommended control patient sample size of 35 is
achieved.
Also related to Aim 2, actual adherence and completion of CR could be
investigated. While the present study sought to differentiate between those who chose to
attend CR or not, no attention was given to success once enrolled in a treatment
paradigm. This direction could include tracking who actually completed rehabilitation to
examine whether success or failure in CR is predicted by any cognitive factors.
Another possible future direction relates to health outcomes. This study shows
that a constellation of health, cognitive reserve, and affective factors impact cognitive
functioning in heart patients. Since impaired cognitive functioning is often associated
with poorer health outcomes (Kakos, et al., 2010; Moser, et al., 1999; Vogels,
Oosterman, et al., 2007; Vogels, Scheltens, et al., 2007), it is likely that addressing the
influencing factors described in this study can reduce patient morbidity and mortality. To
formally test this hypothesis, it will be important to formulate and test models that
describe the impact health, cognitive reserve, and affective predictors have on health
outcomes when mediated by cognitive factors. Such studies are likely to help us better
interpret and understand the clinical applicability of the current study.
A future direction could also include examining the effects that a treatment
paradigm has on heart patients’ cognitive abilities. This could include testing patients
directly after a heart diagnosis is made and at post-treatment. While some treatments,
such as POCD, are well-documented (Ropacki, et al., 2007), particularly after CABG and

95

other procedures, it would be useful to examine the effects of less invasive procedures,
such as laparoscopic surgeries, pharmacotherapies, and other modalities.
Finally, a future direction could include stratifying patients based on their
presenting problem (e.g., CHF, MI, etc.), to further study the effects that disparate heart
diagnoses have on cognitive ability. In addition, researchers may consider studying the
potential interaction between diagnosis and treatment modality.
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